It
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended May 31, 20222023
Commission File Number: 1-9852
CHASE CORPORATION
(Exact name of registrant as specified in its charter)
| | |
Massachusetts | | 11-1797126 |
(State or other jurisdiction of incorporation | | (I.R.S. Employer Identification No.) |
375 University Avenue, Westwood, Massachusetts 02090
(Address of Principal Executive Offices) (Zip Code)
(781) 332-0700
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| ||
| ||
Title of each class Common stock, $.10 par value | Trading Symbol(s) CCF | Name of each exchange on which registered NYSE American |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. YES⌧ NO ◻
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES⌧ NO ◻
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| |
Large accelerated filer ◻ | Accelerated filer ⌧ |
Non-accelerated filer ◻ | Smaller reporting company ☐ |
Emerging growth company ☐ | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻
Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ⌧
The number of shares of Common Stock outstanding as of June 30, 20222023 was 9,468,590.9,506,344.
CHASE CORPORATION
INDEX TO FORM 10-Q
For the Quarter Ended May 31, 20222023
Ca | | |
| 3 | |
| | |
Part I - FINANCIAL INFORMATION | | |
| | |
Item 1 – Unaudited Condensed Consolidated Financial Statements | | |
| | |
Condensed Consolidated Balance Sheets as of May 31, | | 4 |
| | |
| 5 | |
| | |
| 6 | |
| | |
| 7 | |
| | |
| 9 | |
| | |
Notes to Unaudited Condensed Consolidated Financial Statements | | 10 |
| | |
Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
|
| | |
Item 3 – Quantitative and Qualitative Disclosures About Market Risk | |
|
| | |
|
| |
| | |
| | |
| | |
|
| |
| | |
|
| |
| | |
|
| |
| | |
|
|
2
Cautionary Note Concerning Forward-Looking Statements
This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, including without limitation forward-looking statements made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” involve risks and uncertainties. Any statements contained in this Quarterly Report that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include, without limitation, statements as to future operating results; seasonality expectations; plans for the development, utilization or disposal of manufacturing facilities; future economic conditions; our expectations as to legal proceedings; the effect of our market and product development efforts; and expectations or plans relating to the implementation or realization of our strategic goals and future growth, including through potential future acquisitions. Forward-looking statements may also include, among other things, statements relating to future sales, earnings, cash flow, results of operations, use of cash and other measures of financial performance, and statements relating to future dividend payments, as well as the expected impact of the coronavirus disease 2019 (COVID-19) pandemic on the Company's businesses. Forward-looking statements may be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “predicts,” “targets,” “forecasts,” “strategy,” and other words of similar meaning in connection with the discussion of future operating or financial performance. These statements are based on current expectations, estimates and projections about the industries in which we operate, and the beliefs and assumptions made by management. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Accordingly, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. ReadersInvestors should refer to the discussions under “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 20212022, concerning certain factors that could cause our actual results to differ materially from the results anticipated in such forward-looking statements. These Risk Factors are hereby incorporated by reference into this Quarterly Report.
3
Item 1 — Unaudited Condensed Consolidated Financial Statements
CHASE CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
In thousands, except share and per share amounts
| | | | | | | |
| | May 31, | | August 31, | | ||
|
| 2022 |
| 2021 |
| ||
ASSETS | | | | | | | |
Current Assets | | | | | | | |
Cash and cash equivalents | | $ | 124,683 | | $ | 119,429 | |
Accounts receivable, less allowances of $537 and $451 | | | 51,330 | | | 46,212 | |
Inventory | | | 58,551 | | | 41,217 | |
Prepaid expenses and other current assets | | | 3,434 | | | 2,851 | |
Prepaid income taxes and refunds due | | | 3,249 | | | 3,255 | |
Total current assets | | | 241,247 | | | 212,964 | |
| | | | | | | |
Property, plant and equipment, less accumulated depreciation of $52,154 and $50,666 | | | 24,531 | | | 24,267 | |
| | | | | | | |
Other Assets | | | | | | | |
Goodwill | | | 96,321 | | | 97,866 | |
Intangible assets, less accumulated amortization of $99,506 and $91,484 | | | 36,947 | | | 46,954 | |
Cash surrender value of life insurance | | | 4,450 | | | 4,450 | |
Restricted investments | | | 2,312 | | | 2,260 | |
Deferred income taxes | | | 5,273 | | | 5,265 | |
Operating lease right-of-use asset | | | 9,078 | | | 9,312 | |
Other assets | | | 732 | | | 821 | |
Total assets | | $ | 420,891 | | $ | 404,159 | |
| | | | | | | |
LIABILITIES AND EQUITY | | | | | | | |
Current Liabilities | | | | | | | |
Accounts payable | | $ | 18,375 | | $ | 19,575 | |
Accrued payroll and other compensation | | | 5,884 | | | 7,179 | |
Income taxes payable | | | 159 | | | 761 | |
Accrued expenses | | | 5,639 | | | 5,407 | |
Total current liabilities | | | 30,057 | | | 32,922 | |
| | | | | | | |
Operating lease long-term liabilities | | | 7,060 | | | 7,202 | |
Deferred compensation | | | 2,320 | | | 2,267 | |
Accumulated pension obligation | | | 8,155 | | | 9,416 | |
Other liabilities | | | 2,099 | | | 2,537 | |
Deferred income taxes | | | 2,822 | | | 3,301 | |
Accrued income taxes | | | 1,813 | | | 2,190 | |
| | | | | | | |
Commitments and contingencies (Note 10) | | | | | | | |
| | | | | | | |
Equity | | | | | | | |
First Serial Preferred Stock, $1.00 par value: Authorized 100,000 shares; NaN issued | | | — | | | — | |
Common stock, $.10 par value: Authorized 20,000,000 shares; 9,468,590 shares at May 31, 2022 and 9,447,905 shares at August 31, 2021 issued and outstanding | | | 948 | | | 946 | |
Additional paid-in capital | | | 21,375 | | | 18,959 | |
Accumulated other comprehensive loss | | | (16,325) | | | (11,210) | |
Retained earnings | | | 360,567 | | | 335,629 | |
Total equity | | | 366,565 | | | 344,324 | |
Total liabilities and equity | | $ | 420,891 | | $ | 404,159 | |
| | | | | | | |
| | | | | | | |
| | May 31, | | August 31, | | ||
|
| 2023 |
| 2022 |
| ||
| | (unaudited) | | | | | |
ASSETS | | | | | | | |
Current Assets | | | | | | | |
Cash and cash equivalents | | $ | 43,071 | | $ | 315,495 | |
Accounts receivable, less allowances of $840 and $610 | | | 61,112 | | | 51,540 | |
Inventory | | | 77,485 | | | 63,039 | |
Prepaid expenses and other current assets | | | 9,720 | | | 4,374 | |
Prepaid income taxes and refunds due | | | 4,988 | | | 2,329 | |
Total current assets | | | 196,376 | | | 436,777 | |
| | | | | | | |
Property, plant and equipment, less accumulated depreciation of $59,433 and $52,503 | | | 61,918 | | | 24,248 | |
| | | | | | | |
Other Assets | | | | | | | |
Goodwill | | | 177,736 | | | 95,160 | |
Intangible assets, less accumulated amortization of $120,706 and $101,237 | | | 163,954 | | | 33,661 | |
Cash surrender value of life insurance | | | 4,450 | | | 4,450 | |
Restricted investments | | | 2,672 | | | 2,367 | |
Deferred income taxes | | | 10 | | | 5,763 | |
Operating lease right-of-use assets | | | 7,341 | | | 8,596 | |
Other assets | | | 2,839 | | | 558 | |
Total assets | | $ | 617,296 | | $ | 611,580 | |
| | | | | | | |
LIABILITIES AND EQUITY | | | | | | | |
Current Liabilities | | | | | | | |
Accounts payable | | $ | 20,662 | | $ | 20,122 | |
Accrued payroll and other compensation | | | 5,822 | | | 6,381 | |
Income taxes payable | | | 466 | | | 554 | |
Accrued expenses | | | 11,132 | | | 8,271 | |
Total current liabilities | | | 38,082 | | | 35,328 | |
| | | | | | | |
Long-term debt | | | 130,000 | | | 180,000 | |
Operating lease long-term liabilities | | | 5,449 | | | 6,618 | |
Deferred compensation | | | 2,683 | | | 2,375 | |
Accumulated pension obligation | | | 6,655 | | | 7,431 | |
Other liabilities | | | 3,655 | | | 2,897 | |
Deferred income taxes | | | 31,221 | | | 2,282 | |
Accrued income taxes | | | 1,982 | | | 1,820 | |
Total liabilities | | $ | 219,727 | | $ | 238,751 | |
| | | | | | | |
Commitments and contingencies (Note 10) | | | | | | | |
| | | | | | | |
Equity | | | | | | | |
First Serial Preferred Stock, $1.00 par value: Authorized 100,000 shares; none issued | | | — | | | — | |
Common stock, $.10 par value: Authorized 20,000,000 shares; 9,506,344 shares at May 31, 2023 and 9,462,765 shares at August 31, 2022 issued and outstanding | | | 952 | | | 947 | |
Additional paid-in capital | | | 23,820 | | | 21,409 | |
Accumulated other comprehensive loss | | | (15,862) | | | (20,367) | |
Retained earnings | | | 388,659 | | | 370,840 | |
Total equity | | | 397,569 | | | 372,829 | |
Total liabilities and equity | | $ | 617,296 | | $ | 611,580 | |
| | | | | | | |
See accompanying notes to the unaudited condensed consolidated financial statements
4
CHASE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
In thousands, except share and per share amounts
| | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | ||||||||
|
| 2022 |
| 2021 |
| | 2022 |
| 2021 |
| | ||||
| | | | | | | | | | | | | | | |
Revenue | | | | | | | | | | | | | | | |
Sales | | $ | 87,724 | | $ | 78,822 | | | $ | 235,098 | | $ | 212,533 | | |
Royalties and commissions | | | 895 | | | 771 | | | | 2,484 | | | 2,683 | | |
| | | 88,619 | | | 79,593 | | | | 237,582 | | | 215,216 | | |
Costs and Expenses | | | | | | | | | | | | | | | |
Cost of products and services sold | | | 54,438 | | | 46,312 | | | | 148,630 | | | 126,832 | | |
Selling, general and administrative expenses | | | 13,807 | | | 13,969 | | | | 40,307 | | | 38,560 | | |
Research and product development costs | | | 1,186 | | | 957 | | | | 3,274 | | | 3,034 | | |
Operations optimization costs (Note 15) | | | 59 | | | 22 | | | | 707 | | | 120 | | |
Acquisition-related costs (Note 17) | | | — | | | — | | | | — | | | 128 | | |
(Gain) loss on contingent consideration (Note 17) | | | (474) | | | 262 | | | | (199) | | | 995 | | |
| | | | | | | | | | | | | | | |
Operating income | | | 19,603 | | | 18,071 | | | | 44,863 | | | 45,547 | | |
| | | | | | | | | | | | | | | |
Interest expense | | | (89) | | | (68) | | | | (262) | | | (204) | | |
Other income (expense) | | | (166) | | | (260) | | | | 231 | | | (758) | | |
| | | | | | | | | | | | | | | |
Income before income taxes | | | 19,348 | | | 17,743 | | | | 44,832 | | | 44,585 | | |
| | | | | | | | | | | | | | | |
Income taxes (Note 14) | | | 3,803 | | | 3,454 | | | | 10,434 | | | 10,288 | | |
| | | | | | | | | | | | | | | |
Net income | | $ | 15,545 | | $ | 14,289 | | | $ | 34,398 | | $ | 34,297 | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Net income available to common shareholders, per common and common equivalent share (Note 4) | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Basic | | $ | 1.64 | | $ | 1.51 | | | $ | 3.64 | | $ | 3.63 | | |
| | | | | | | | | | | | | | | |
Diluted | | $ | 1.64 | | $ | 1.50 | | | $ | 3.62 | | $ | 3.61 | | |
| | | | | | | | | | | | | | | |
Weighted average shares outstanding | | | | | | | | | | | | | | | |
Basic | | | 9,399,231 | | | 9,386,814 | | | | 9,398,778 | | | 9,381,433 | | |
Diluted | | | 9,431,259 | | | 9,435,335 | | | | 9,435,369 | | | 9,426,879 | | |
| | | | | | | | | | | | | | | |
Annual cash dividends declared per share | | | — | | | — | | | $ | 1.00 | | $ | 0.80 | | |
| | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | ||||||||
|
| 2023 |
| 2022 |
| | 2023 |
| 2022 |
| | ||||
| | (unaudited) | | | (unaudited) | | | ||||||||
Revenue | | | | | | | | | | | | | | | |
Sales | | $ | 105,821 | | $ | 87,724 | | | $ | 301,459 | | $ | 235,098 | | |
Royalties and commissions | | | 824 | | | 895 | | | | 2,359 | | | 2,484 | | |
| | | 106,645 | | | 88,619 | | | | 303,818 | | | 237,582 | | |
Costs and Expenses | | | | | | | | | | | | | | | |
Cost of products and services sold | | | 66,437 | | | 54,438 | | | | 193,058 | | | 148,630 | | |
Selling, general and administrative expenses | | | 19,189 | | | 13,807 | | | | 59,232 | | | 40,307 | | |
Research and product development costs | | | 1,527 | | | 1,186 | | | | 4,481 | | | 3,274 | | |
Operations optimization costs (Note 15) | | | 215 | | | 59 | | | | 1,506 | | | 707 | | |
Acquisition-related costs (Note 17) | | | — | | | — | | | | 29 | | | — | | |
Loss on impairment/write-off of long-term assets (Note 8, 15) | | | 331 | | | — | | | | 1,193 | | | — | | |
Loss (Gain) on contingent consideration (Note 12) | | | 129 | | | (474) | | | | 563 | | | (199) | | |
| | | | | | | | | | | | | | | |
Operating income | | | 18,817 | | | 19,603 | | | | 43,756 | | | 44,863 | | |
| | | | | | | | | | | | | | | |
Interest expense | | | (2,361) | | | (89) | | | | (6,886) | | | (262) | | |
Other (expense) income | | | (308) | | | (166) | | | | (1,130) | | | 231 | | |
| | | | | | | | | | | | | | | |
Income before income taxes | | | 16,148 | | | 19,348 | | | | 35,740 | | | 44,832 | | |
| | | | | | | | | | | | | | | |
Income taxes (Note 14) | | | 4,056 | | | 3,803 | | | | 8,421 | | | 10,434 | | |
| | | | | | | | | | | | | | | |
Net income | | $ | 12,092 | | $ | 15,545 | | | $ | 27,319 | | $ | 34,398 | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Net income available to common shareholders, per common and common equivalent share (Note 4) | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Basic | | $ | 1.27 | | $ | 1.64 | | | $ | 2.88 | | $ | 3.64 | | |
| | | | | | | | | | | | | | | |
Diluted | | $ | 1.27 | | $ | 1.64 | | | $ | 2.87 | | $ | 3.62 | | |
| | | | | | | | | | | | | | | |
Weighted average shares outstanding | | | | | | | | | | | | | | | |
Basic | | | 9,430,065 | | | 9,399,231 | | | | 9,422,783 | | | 9,398,778 | | |
Diluted | | | 9,463,355 | | | 9,431,259 | | | | 9,450,668 | | | 9,435,369 | | |
| | | | | | | | | | | | | | | |
Annual cash dividends declared per share | | $ | — | | $ | — | | | $ | 1.00 | | $ | 1.00 | | |
See accompanying notes to the unaudited condensed consolidated financial statements
5
CHASE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
In thousands, except share and per share amounts
| | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | Nine Months Ended May 31, | | | ||||||||
|
| 2022 |
| 2021 |
| 2022 | | 2021 | |
| ||||
Net income | | $ | 15,545 |
| $ | 14,289 | | $ | 34,398 | | $ | 34,297 | | |
| | | | | | | | | | | | | | |
Other comprehensive income (loss): | | | | | | | | | | | | | | |
Net unrealized (loss) gain on restricted investments, net of tax | | | (112) | | | 68 | | | (277) | | | 186 | | |
Change in funded status of pension plans, net of tax | | | 112 | | | 124 | | | 336 | | | 371 | | |
Foreign currency translation adjustment | | | (3,116) | | | 1,386 | | | (5,174) | | | 3,273 | | |
Total other comprehensive income (loss) | | | (3,116) | | | 1,578 | | | (5,115) | | | 3,830 | | |
| | | | | | | | | | | | | | |
Comprehensive income | | $ | 12,429 | | $ | 15,867 | | $ | 29,283 | | $ | 38,127 | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | ||||||||
|
| 2023 |
| 2022 | |
| 2023 | | 2022 | |
| ||||
| | (unaudited) | | | (unaudited) | | | ||||||||
Net income | | $ | 12,092 |
| $ | 15,545 | | | $ | 27,319 | | $ | 34,398 | | |
| | | | | | | | | | | | | | | |
Other comprehensive income (loss): | | | | | | | | | | | | | | | |
Net unrealized gain (loss) on restricted investments, net of tax | | | 36 | | | (112) | | | | 4 | | | (277) | | |
Change in funded status of pension plans, net of tax | | | 65 | | | 112 | | | | 279 | | | 336 | | |
Pension settlement loss (gain), net of tax | | | (68) | | | — | | | | 158 | | | — | | |
Foreign currency translation adjustment | | | 1,375 | | | (3,116) | | | | 4,064 | | | (5,174) | | |
Total other comprehensive income (loss) | | | 1,408 | | | (3,116) | | | | 4,505 | | | (5,115) | | |
| | | | | | | | | | | | | | | |
Comprehensive income | | $ | 13,500 | | $ | 12,429 | | | $ | 31,824 | | $ | 29,283 | | |
| | | | | | | | | | | | | | | |
See accompanying notes to the unaudited condensed consolidated financial statements
6
CHASE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
THREE MONTHS ENDED MAY 31, 20222023 AND 20212022
(UNAUDITED)
In thousands, except share and per share amounts
| | | | | | | | | | | | | | | | | |
| | | | | | | Additional | | Accumulated Other | | | | | Total | |||
| | Common Stock | | Paid-In | | Comprehensive | | Retained | | Stockholders' | |||||||
|
| Shares |
| Amount |
| Capital |
| Income (Loss) |
| Earnings |
| Equity | |||||
Balance at February 28, 2021 | | 9,448,371 | | $ | 946 | | $ | 17,721 | | $ | (10,840) | | $ | 310,717 | | $ | 318,544 |
Amortization of restricted stock grants | | | | | | | | 600 | | | | | | | | | 600 |
Amortization of stock option grants | | | | | | | | 195 | | | | | | | | | 195 |
Exercise of stock options | | 2,149 | | | — | | | 166 | | | | | | | | | 166 |
Common stock received for payment of stock option exercises | | (689) | | | — | | | (80) | | | | | | | | | (80) |
Common stock retained to pay statutory minimum withholding taxes on common stock | | (45) | | | — | | | (6) | | | | | | | | | (6) |
Change in funded status of pension plans, net of tax $41 | | | | | | | | | | | 124 | | | | | | 124 |
Foreign currency translation adjustment | | | | | | | | | | | 1,386 | | | | | | 1,386 |
Net unrealized gain (loss) on restricted investments, net of tax $24 | | | | | | | | | | | 68 | | | | | | 68 |
Net income | | | | | | | | | | | | | | 14,289 | | | 14,289 |
Balance at May 31, 2021 | | 9,449,786 | | $ | 946 | | $ | 18,596 | | $ | (9,262) | | $ | 325,006 | | $ | 335,286 |
| | | | | | | | | | | | | | | | | |
Balance at February 28, 2022 | | 9,468,888 | | $ | 948 | | $ | 20,513 | | $ | (13,209) | | $ | 345,022 | | $ | 353,274 |
Restricted stock grants, net of forfeitures | | (298) | | | — | | | | | | | | | | | | — |
Amortization of restricted stock grants | | | | | | | | 613 | | | | | | | | | 613 |
Amortization of stock option grants | | | | | | | | 249 | | | | | | | | | 249 |
Change in funded status of pension plans, net of tax $37 | | | | | | | | | | | 112 | | | | | | 112 |
Foreign currency translation adjustment | | | | | | | | | | | (3,116) | | | | | | (3,116) |
Net unrealized gain (loss) on restricted investments, net of tax ($37) | | | | | | | | | | | (112) | | | | | | (112) |
Net income | | | | | | | | | | | | | | 15,545 | | | 15,545 |
Balance at May 31, 2022 | | 9,468,590 | | $ | 948 | | $ | 21,375 | | $ | (16,325) | | $ | 360,567 | | $ | 366,565 |
| | | | | | | | | | | | | | | | | |
See accompanying notes to the unaudited condensed consolidated financial statements
7
CHASE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
NINE MONTHS ENDED MAY 31, 2022 AND 2021
(UNAUDITED)
In thousands, except share and per share amounts
| | | | | | | | | | | | | | | | | |
| | | | | | | Additional | | Accumulated Other | | | | | Total | |||
| | Common Stock | | Paid-In | | Comprehensive | | Retained | | Stockholders' | |||||||
|
| Shares |
| Amount |
| Capital |
| Income (Loss) |
| Earnings |
| Equity | |||||
Balance at August 31, 2020 | | 9,439,082 | | $ | 944 | | $ | 16,674 | | $ | (13,092) | | $ | 298,266 | | $ | 302,792 |
Restricted stock grants, net of forfeitures | | 10,693 | | | 2 | | | (2) | | | | | | | | | — |
Amortization of restricted stock grants | | | | | | | | 1,789 | | | | | | | | | 1,789 |
Amortization of stock option grants | | | | | | | | 420 | | | | | | | | | 420 |
Exercise of stock options | | 4,681 | | | — | | | 207 | | | | | | | | | 207 |
Common stock received for payment of stock option exercises | | (1,075) | | | — | | | (121) | | | | | | | | | (121) |
Common stock retained to pay statutory minimum withholding taxes on common stock | | (3,595) | | | — | | | (371) | | | | | | | | | (371) |
Cash dividend on common stock, $0.80 per share | | | | | | | | | | | | | | (7,557) | | | (7,557) |
Change in funded status of pension plans, net of tax $124 | | | | | | | | | | | 371 | | | | | | 371 |
Foreign currency translation adjustment | | | | | | | | | | | 3,273 | | | | | | 3,273 |
Net unrealized gain (loss) on restricted investments, net of tax $63 | | | | | | | | | | | 186 | | | | | | 186 |
Net income | | | | | | | | | | | | | | 34,297 | | | 34,297 |
Balance at May 31, 2021 | | 9,449,786 | | $ | 946 | | $ | 18,596 | | $ | (9,262) | | $ | 325,006 | | $ | 335,286 |
| | | | | | | | | | | | | | | | | |
Balance at August 31, 2021 | | 9,447,905 | | $ | 946 | | $ | 18,959 | | $ | (11,210) | | $ | 335,629 | | $ | 344,324 |
Restricted stock grants, net of forfeitures | | 20,685 | | | 2 | | | (2) | | | | | | | | | — |
Amortization of restricted stock grants | | | | | | | | 1,721 | | | | | | | | | 1,721 |
Amortization of stock option grants | | | | | | | | 697 | | | | | | | | | 697 |
Cash dividend on common stock, $1.00 per share | | | | | | | | | | | | | | (9,460) | | | (9,460) |
Change in funded status of pension plans, net of tax $111 | | | | | | | | | | | 336 | | | | | | 336 |
Foreign currency translation adjustment | | | | | | | | | | | (5,174) | | | | | | (5,174) |
Net unrealized gain (loss) on restricted investments, net of tax ($92) | | | | | | | | | | | (277) | | | | | | (277) |
Net income | | | | | | | | | | | | | | 34,398 | | | 34,398 |
Balance at May 31, 2022 | | 9,468,590 | | $ | 948 | | $ | 21,375 | | $ | (16,325) | | $ | 360,567 | | $ | 366,565 |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | Additional | | Accumulated Other | | | | | Total | |||
| | Common Stock | | Paid-In | | Comprehensive | | Retained | | Stockholders' | |||||||
|
| Shares |
| Amount |
| Capital |
| Income (Loss) |
| Earnings |
| Equity | |||||
Balance at February 28, 2022 (unaudited) | | 9,468,888 | | $ | 948 | | $ | 20,513 | | $ | (13,209) | | $ | 345,022 | | $ | 353,274 |
Restricted stock grants, net of forfeitures | | (298) | | | — | | | — | | | — | | | — | | | — |
Amortization of restricted stock grants | | | | | — | | | 613 | | | — | | | — | | | 613 |
Amortization of stock option grants | | | | | — | | | 249 | | | — | | | — | | | 249 |
Change in funded status of pension plans, net of tax $37 | | | | | — | | | — | | | 112 | | | — | | | 112 |
Foreign currency translation adjustment | | | | | — | | | — | | | (3,116) | | | — | | | (3,116) |
Net unrealized gain (loss) on restricted investments, net of tax ($37) | | | | | — | | | — | | | (112) | | | — | | | (112) |
Net income | | | | | — | | | — | | | — | | | 15,545 | | | 15,545 |
Balance at May 31, 2022 (unaudited) | | 9,468,590 | | $ | 948 | | $ | 21,375 | | $ | (16,325) | | $ | 360,567 | | $ | 366,565 |
| | | | | | | | | | | | | | | | | |
Balance at February 28, 2023 (unaudited) | | 9,506,127 | | $ | 952 | | $ | 23,111 | | $ | (17,270) | | $ | 376,567 | | $ | 383,360 |
Restricted stock grants, net of forfeitures | | 963 | | | — | | | — | | | — | | | — | | | — |
Amortization of restricted stock grants | | | | | — | | | 556 | | | — | | | — | | | 556 |
Amortization of stock option grants | | | | | — | | | 227 | | | — | | | — | | | 227 |
Common stock retained to pay statutory minimum withholding taxes on common stock | | (746) | | | — | | | (74) | | | — | | | — | | | (74) |
Change in funded status of pension plans, net of tax $21 | | | | | — | | | — | | | 65 | | | — | | | 65 |
Pension settlement loss (gain), net of tax ($23) | | | | | — | | | — | | | (68) | | | — | | | (68) |
Foreign currency translation adjustment | | | | | — | | | — | | | 1,375 | | | — | | | 1,375 |
Net unrealized gain (loss) on restricted investments, net of tax $13 | | | | | — | | | — | | | 36 | | | — | | | 36 |
Net income | | | | | — | | | — | | | — | | | 12,092 | | | 12,092 |
Balance at May 31, 2023 (unaudited) | | 9,506,344 | | $ | 952 | | $ | 23,820 | | $ | (15,862) | | $ | 388,659 | | $ | 397,569 |
| | | | | | | | | | | | | | | | | |
See accompanying notes to the unaudited condensed consolidated financial statements
7
CHASE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
NINE MONTHS ENDED MAY 31, 2023 AND 2022
In thousands, except share and per share amounts
| | | | | | | | | | | | | | | | | |
| | | | | | | Additional | | Accumulated Other | | | | | Total | |||
| | Common Stock | | Paid-In | | Comprehensive | | Retained | | Stockholders' | |||||||
|
| Shares |
| Amount |
| Capital |
| Income (Loss) |
| Earnings |
| Equity | |||||
Balance at August 31, 2021 | | 9,447,905 | | $ | 946 | | $ | 18,959 | | $ | (11,210) | | $ | 335,629 | | $ | 344,324 |
Restricted stock grants, net of forfeitures | | 20,685 | | | 2 | | | (2) | | | — | | | — | | | — |
Amortization of restricted stock grants | | | | | — | | | 1,721 | | | — | | | — | | | 1,721 |
Amortization of stock option grants | | | | | — | | | 697 | | | — | | | — | | | 697 |
Cash dividend on common stock, $1.00 per share | | | | | — | | | — | | | — | | | (9,460) | | | (9,460) |
Change in funded status of pension plans, net of tax $111 | | | | | — | | | — | | | 336 | | | — | | | 336 |
Foreign currency translation adjustment | | | | | — | | | — | | | (5,174) | | | — | | | (5,174) |
Net unrealized gain (loss) on restricted investments, net of tax ($92) | | | | | — | | | — | | | (277) | | | — | | | (277) |
Net income | | | | | — | | | — | | | — | | | 34,398 | | | 34,398 |
Balance at May 31, 2022 (unaudited) | | 9,468,590 | | $ | 948 | | $ | 21,375 | | $ | (16,325) | | $ | 360,567 | | $ | 366,565 |
| | | | | | | | | | | | | | | | | |
Balance at August 31, 2022 | | 9,462,765 | | $ | 947 | | $ | 21,409 | | $ | (20,367) | | $ | 370,840 | | $ | 372,829 |
Restricted stock grants, net of forfeitures | | 37,922 | | | 4 | | | (4) | | | — | | | — | | | — |
Amortization of restricted stock grants | | | | | — | | | 2,164 | | | — | | | — | | | 2,164 |
Amortization of stock option grants | | | | | — | | | 575 | | | — | | | — | | | 575 |
Exercise of stock options | | 15,152 | | | 2 | | | 555 | | | — | | | — | | | 557 |
Common stock received for payment of stock option exercises | | (6,140) | | | (1) | | | (556) | | | — | | | — | | | (557) |
Common stock retained to pay statutory minimum withholding taxes on common stock | | (3,355) | | | — | | | (323) | | | — | | | — | | | (323) |
Cash dividend on common stock, $1.00 per share | | | | | — | | | — | | | — | | | (9,500) | | | (9,500) |
Change in funded status of pension plans, net of tax $92 | | | | | — | | | — | | | 279 | | | — | | | 279 |
Pension settlement loss, net of tax $53 | | | | | — | | | — | | | 158 | | | — | | | 158 |
Foreign currency translation adjustment | | | | | — | | | — | | | 4,064 | | | — | | | 4,064 |
Net unrealized gain (loss) on restricted investments, net of tax $2 | | | | | — | | | — | | | 4 | | | — | | | 4 |
Net income | | | | | — | | | — | | | — | | | 27,319 | | | 27,319 |
Balance at May 31, 2023 (unaudited) | | 9,506,344 | | $ | 952 | | $ | 23,820 | | $ | (15,862) | | $ | 388,659 | | $ | 397,569 |
| | | | | | | | | | | | | | | | | |
See accompanying notes to the unaudited condensed consolidated financial statements
8
CHASE CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
In thousands
| | | | | | | | | |
| | | Nine Months Ended May 31, | | | ||||
|
| | 2022 |
| 2021 |
|
| ||
CASH FLOWS FROM OPERATING ACTIVITIES | | | | | | | | | |
Net income | | | $ | 34,398 | | $ | 34,297 | | |
Adjustments to reconcile net income to net cash provided by operating activities | | | | | | | | | |
(Gain) Loss on contingent consideration | | | | (199) | | | 995 | | |
Depreciation | | | | 2,654 | | | 2,925 | | |
Amortization | | | | 9,092 | | | 9,566 | | |
Provision for allowance for doubtful accounts | | | | 91 | | | (8) | | |
Stock-based compensation | | | | 2,418 | | | 2,209 | | |
Realized gain on restricted investments | | | | (86) | | | (54) | | |
Deferred taxes | | | | (187) | | | — | | |
Increase (decrease) from changes in assets and liabilities | | | | | | | | | |
Accounts receivable | | | | (5,852) | | | (6,946) | | |
Inventory | | | | (17,768) | | | 2,062 | | |
Prepaid expenses and other assets | | | | (573) | | | (260) | | |
Accounts payable | | | | (936) | | | 3,049 | | |
Accrued compensation and other expenses | | | | (1,765) | | | 49 | | |
Accrued income taxes | | | | (1,001) | | | (4,884) | | |
Net cash provided by operating activities | | | | 20,286 | | | 43,000 | | |
| | | | | | | | | |
CASH FLOWS FROM INVESTING ACTIVITIES | | | | | | | | | |
Purchases of property, plant and equipment | | | | (3,103) | | | (1,749) | | |
Payments for acquisitions | | | | — | | | (31,238) | | |
Changes in restricted investments | | | | (340) | | | (119) | | |
Net cash used in investing activities | | | | (3,443) | | | (33,106) | | |
| | | | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES | | | | | | | | | |
Dividend paid | | | | (9,460) | | | (7,557) | | |
Proceeds from exercise of common stock options | | | | — | | | 86 | | |
Payments of taxes on stock options and restricted stock | | | | — | | | (371) | | |
Net cash used in financing activities | | | | (9,460) | | | (7,842) | | |
| | | | | | | | | |
INCREASE IN CASH & CASH EQUIVALENTS | | | | 7,383 | | | 2,052 | | |
Effect of foreign exchange rates on cash | | | | (2,129) | | | 1,827 | | |
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | | | | 119,429 | | | 99,068 | | |
CASH AND CASH EQUIVALENTS, END OF PERIOD | | | $ | 124,683 | | $ | 102,947 | | |
| | | | | | | | | |
Non-cash Investing and Financing Activities | | | | | | | | | |
Common stock received for payment of stock option exercises | | | $ | — | | $ | 121 | | |
Property, plant and equipment additions included in accounts payable | | | $ | 207 | | $ | 141 | | |
| | | | | | | | | |
| | | Nine Months Ended May 31, | | | ||||
|
| | 2023 |
| 2022 |
|
| ||
| | | (unaudited) | | | ||||
CASH FLOWS FROM OPERATING ACTIVITIES | | | | | | | | | |
Net income | | | $ | 27,319 | | $ | 34,398 | | |
Adjustments to reconcile net income to net cash provided by operating activities | | | | | | | | | |
Loss on impairment/write-off of long-term assets | | | | 1,193 | | | — | | |
Loss on contingent consideration | | | | 563 | | | (199) | | |
Depreciation | | | | 6,708 | | | 2,654 | | |
Amortization | | | | 18,721 | | | 9,092 | | |
Provision for allowance for doubtful accounts | | | | 224 | | | 91 | | |
Stock-based compensation | | | | 2,739 | | | 2,418 | | |
Realized gain on restricted investments | | | | (100) | | | (86) | | |
Pension curtailment and settlement loss | | | | 158 | | | — | | |
Deferred taxes | | | | (3,736) | | | (187) | | |
Increase (decrease) from changes in assets and liabilities | | | | | | | | | |
Accounts receivable | | | | 1,167 | | | (5,852) | | |
Inventory | | | | 2,094 | | | (17,768) | | |
Prepaid expenses and other assets | | | | (2,251) | | | (573) | | |
Accounts payable | | | | (4,587) | | | (936) | | |
Accrued compensation and other expenses | | | | (5,566) | | | (1,765) | | |
Accrued income taxes | | | | (2,831) | | | (1,001) | | |
Net cash provided by operating activities | | | | 41,815 | | | 20,286 | | |
| | | | | | | | | |
CASH FLOWS FROM INVESTING ACTIVITIES | | | | | | | | | |
Purchases of property, plant and equipment | | | | (5,729) | | | (3,103) | | |
Payments for acquisitions, net of cash acquired | | | | (249,594) | | | — | | |
Changes in restricted investments | | | | (200) | | | (340) | | |
Net cash used in investing activities | | | | (255,523) | | | (3,443) | | |
| | | | | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES | | | | | | | | | |
Payments of principal on debt | | | | (50,000) | | | — | | |
Dividend paid | | | | (9,500) | | | (9,460) | | |
Payments of taxes on stock options and restricted stock | | | | (323) | | | — | | |
Net cash used in financing activities | | | | (59,823) | | | (9,460) | | |
| | | | | | | | | |
(DECREASE) INCREASE IN CASH & CASH EQUIVALENTS | | | | (273,531) | | | 7,383 | | |
Effect of foreign exchange rates on cash | | | | 1,107 | | | (2,129) | | |
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | | | | 315,495 | | | 119,429 | | |
CASH AND CASH EQUIVALENTS, END OF PERIOD | | | $ | 43,071 | | $ | 124,683 | | |
| | | | | | | | | |
Non-cash Investing and Financing Activities | | | | | | | | | |
Common stock received for payment of stock option exercises | | | $ | 557 | | $ | — | | |
Property, plant and equipment additions included in accounts payable | | | $ | 418 | | $ | 207 | | |
See accompanying notes to the unaudited condensed consolidated financial statements
9
CHASE CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
In thousands, except share and per share amounts
Note 1 — Basis of Financial Statement Presentation
Description of Business
Chase Corporation (the “Company,” “Chase,” “we,” or “us”), a global specialty chemicals company founded in 1946, is a leading manufacturer of protective materials for high-reliability applications across diverse market sectors. The Company’s strategy is to maximize the performance of its core businesses and brands while seeking future opportunities through strategic acquisitions. Through investments in facilities, systems and organizational consolidation, the Company seeks to improve performance and gain economies of scale.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States of America generally accepted accounting principles (“U.S. GAAP”) for interim financial reporting, and instructions to Form 10-Qwith the rules and Rule 10-01regulations of Regulation S-X.the Securities and Exchange Commission regarding interim financial reporting. Therefore, they do not include all information and footnote disclosures necessary for a complete presentation of Chase Corporation’s financial position, results of operations and cash flows in conformity with generally accepted accounting principles.flows. The year-end condensed balance sheet was derived from audited financial statements but does not include all disclosures required by accounting principles generally accepted in the United States of America. Chase Corporation filed audited consolidated financial statements which included all information and notes necessary for such a complete presentation for the three years ended August 31, 20212022 in conjunction with its 20212022 Annual Report on Form 10-K. Certain immaterial reclassifications may have been made to the prior year amounts to conform to the current year’s presentation.
Unless otherwise indicated, all references to a year mean our fiscal year, which ends on August 31.
The results of operations for the interim period ended May 31, 20222023 are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended August 31, 20212022 which are contained in the Company’s 20212022 Annual Report on Form 10-K.
The accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring items) that are, in the opinion of management, necessary for a fair statement of the Company’s financial position as of May 31, 2022,2023, and the results of its operations, comprehensive income, changes in equity and cash flows for the interim periods ended May 31, 20222023 and 2021.2022.
The financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company uses the U.S. dollar as the reporting currency for financial reporting. The financial position and results of operations of the Company’s U.K.-based operations are measured using the British pound as the functional currency. The financial position and results of operations of the Company’s operations based in France, including the operations of NuCera Solutions in France, are measured using the euro as the functional currency. The financial position and results of the Company’s HumiSeal India Private Limited business are measured using the Indian rupee as the functional currency. The financial position and results of operations of the NuCera Solutions operations in Singapore are measured using the Singapore dollar as the functional currency. The functional currency for all Chase Corporation’sof the Company’s other operations is the U.S. dollar. Foreign currency translation gains and losses are determined using current exchange rates for monetary items and historical exchange rates for other balance sheet items and are recorded as a change in other comprehensive income. Transaction gains and losses generated from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of each applicable operation are included in other income (expense) on the condensed consolidated statements of operations, and were were$(368) and $(654) for the three- and nine month periods ended May 31, 2023, respectively, and $94 and $431 for the three- and nine-month periods ended May 31, 2022, respectively, and ($241) and ($678) for the three- and nine-month periods ended May 31, 2021, respectively.
10
Other Business Developments
Acquisition of NuCera Solutions
On September 1, 2022 (the first day of fiscal 2023), the Company acquired all of the capital stock of NuCera Solutions (“NuCera”) for a purchase price of $250,000, net of debt, accrued income taxes and cash at closing, and working capital adjustments. The purchase was funded by utilizing $180,000 from the Company’s existing revolving credit facility and the remaining $70,000 from available cash on hand. The Company recorded transaction costs of $29 in the first quarter of fiscal 2023 and $4,000 in the fourth quarter of fiscal 2022 related to this acquisition which are excluded from the purchase price. NuCera is a recognized global leader in the production and development of highly differentiated specialty polymers and polymerization technologies serving demanding applications, offering products critical to enabling end-product functionality, performance and reliability. Chase will continue to market under NuCera brands and the business is integrated into Chase’s Adhesives, Sealants and Additives reporting unit for fiscal 2023.
ERP System Upgrade
During the first quarter of fiscal 2023, the Company began the process of upgrading the current Oracle Legacy ERP System to the Oracle Fusion Cloud Platform. This upgrade will position us with a more advanced system to support business expansion, access to upgrades in functionality and a more modern system for operations. Additionally, the upgrade will be a multi-year, phased-in approach designed to mitigate any disruptions to our business. The Company recognized $133 and $990 in expense related to the ERP System upgrade in the third quarter and year-to-date periods, respectively, of fiscal 2023. Additionally, the Company capitalized $1,264 and $2,250 related to the ERP system upgrade in the third quarter and year-to-date periods, respectively, of fiscal 2023. Capitalized ERP is included in prepaid expenses and non-current other assets.
Relocation of previous NuCera Corporate and R&D headquarters
During the third quarter of 2023 Chase moved out of the Woodlands, TX facility (previously NuCera Corporate and R&D headquarters) to a smaller R&D facility in Houston, TX. On the last day of the third fiscal quarter, the Company signed a sublease agreement for the Woodlands office and expensed $211 as a lease impairment related to this facility in the third quarter of the fiscal period. The project is now substantially complete, and any future costs related to the facility relocation are not anticipated to be significant to the condensed consolidated financial statements.
The Company wrote-off $120 of fixed assets primarily related to the R&D relocation of the Houston, TX facility in the third quarter and year-to-date period of fiscal 2023.
Relocation of Adhesives Systems Manufacturing to O'Hara Township, PA
During the third quarter of fiscal 2021 Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. Chase Corporation obtained the adhesives systems operations as part of its fiscal 2017 acquisition of the operations of Resin Designs. The Company expensed $82 and $516 related to the consolidation of the Woburn, MA location and Woburn, MA facility closure during the third quarter and year-to-date period of fiscal 2023. The Company expensed $27 and $328 related to the consolidation of the Woburn, MA location during the third quarter and year-to-date period of fiscal 2022.
On the last day of the second quarter of 2023, the Company signed a termination agreement with the landlord for the Woburn, MA facility and wrote off the right-of-use asset and liability of the Woburn, MA lease, expensing $314 in the second fiscal quarter of 2023. Additionally, the Company expensed $548 as a lease impairment related to the Woburn, MA facility in the first quarter of fiscal 2023. The total combined year-to-date expense of $862 related to the Woburn, MA facility is included in the Loss on impairment/write-off of long-term assets in the Condensed Consolidated Statement of Operations. The project is now substantially complete and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.
Relocation of Chase Corporate Headquarters
The Company completed the relocation of its Corporate Headquarterscorporate headquarters to another location within Westwood, MA during the second quarter of the fiscal year.year ending August 31, 2022. The move, part of the Company’s ongoing consolidation and optimization initiative, capitalizes on the hybrid work model utilized by many of Chase’s corporate and administrative employees and is expected to provide future operational cost savings. The new facility also consolidates and houses research and development operations previously conducted at the previous Westwood, MA and Woburn, MA locations. Operations
11
optimization costs related to the Westwood move of $32 and $232 were expensed in the third quarter and year-to-date period of fiscal period, respectively.2022. The Company does not anticipate any significant additional operations optimization costs related to the new Corporate Headquarters during the fourth quarterrelocation of the Company’s corporate headquarters is complete and no costs are expected in fiscal year.2023.
During the third quarterRelocation of fiscal 2021, Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. This rationalization and consolidation initiative aligns with the announcement in the second quarter of fiscal 2021 of the Company’s plan to move its sealant systems production from Newark, CASystems Manufacturing to Hickory, NC described in more detail below. Chase Corporation obtained both the adhesive and sealants systems as part of its fiscal 2017 acquisition of the operations of Resin Designs. The Company expensed $27 and $328 related to the consolidation of the Woburn, MA location during the third quarter and year-to-date fiscal period, respectively, and expects to recognize additional expense during the fourth quarter of the fiscal year.
On February 5, 2021, the Company acquired certain assets of Emerging Technologies, Inc. (“ETi”), a superabsorbent polymers solutions provider, located in Greensboro, NC. The business was acquired for a purchase price of $9,997 comprising $8,997 paid on February 5, 2021 and an accrual of $1,000 to be paid out up to eighteen months after purchase, subsequent to final working capital adjustments, and excluding acquisition-related costs. As part of this transaction, Chase acquired substantially all working capital and fixed assets of the business and entered a multi-year lease at ETi’s existing location. The Company expensed $128 of acquisition-related costs during the second quarter of fiscal 2021 associated with this acquisition. The purchase was funded with available cash on hand. ETi is a solutions provider and formulator of absorbent polymers for use in the packaging, recreational, consumer, and sanitation markets. The acquisition broadens the Company’s superabsorbent polymers product offerings and formulation capabilities while expanding its market reach. The Company finalized purchase accounting during the first quarter of fiscal 2022, with no significant change to amounts initially recorded. Since the effective date of the acquisition, the financial results of ETi’s acquired operations have been included in the Company’s financial statements within the functional additives product line, contained within the Adhesives, Sealants and Additives operating segment.
During the second quarter of fiscal 2021, Chase began moving the sealant systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, from its Newark, CA location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. The sealant systems operations and Newark, CA location came to Chase Corporation as part of the fiscal 2017 acquisition of the operations of Resin Designs, and the Company’s lease there terminated in fiscal 2021. The Company recognized $977$0 and $147 in expense related to the move during the entire prior fiscal year ended August 31, 2021third quarter and $147 of expense in the first halfyear-to-date period of fiscal 2022. This project is now substantially completed and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.
11
On September 1, 2020 (the first day of fiscal 2021), the Company acquired all the capital stock of ABchimie for €18,654 (approximately $22,241 at the time of the transaction) net of cash acquired, subsequent to final working capital adjustment, excluding acquisition-related costs totaling $274 recognized in fiscal 2020 and with a potential earn out based on performance potentially worth an additional €7,000 (approximately $8,330 at the time of the transaction). ABchimie is a Corbelin, France headquartered solutions provider for the cleaning and protection of electronic assemblies, with further formulation, production, and research and development capabilities. The transaction was funded with cash on hand. Since the effective date of the acquisition, the financial results of the business have been included in the Company's financial statements within the Adhesives, Sealants and Additives operating segment in the electronic and industrial coatings product line.
Significant Accounting Policies
The Company’s significant accounting policies are detailed in Note 1— “Summary of Significant Accounting Policies” within Item 8 of the Company’s Annual Report on Form 10-K for the year ended August 31, 2021.2022. See Note 2 of the condensed consolidated financial statementsfor a discussion of the effects of recently issued accounting pronouncements.
12
Note 2 — Recent Accounting Standards
Recently IssuedAdopted Accounting Pronouncements - Fiscal 2023
In November 2021,No new accounting pronouncements were adopted in the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-10, “Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance”, which requires entities to make annual disclosures about transactions with a government they account for by analogizing to a grant or contribution accounting model under ASC 958-605. The ASU is effective for the Company beginning September 1, 2022 (the start ofthird quarter and year-to-date fiscal 2023). ASU 2021-10 has not had, and the Company does not expect it to have in future periods, a material impact on the Company’s condensed consolidated financial statements and disclosures.2023 period.
Recently Adopted Accounting Pronouncements
In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers”, which amends the accounting for contract assets and contract liabilities from revenue contracts with customers in a business combination. The amendment requires that an entity acquiring the contract assets and contract liabilities in a business combination be recognized in accordance with ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”. The ASU is effective for all public entities for fiscal years beginning after December 15, 2022, and interim periods therein. The Company early adopted ASU 2021-08 on February 28, 2022 and any impact on the condensed consolidated financial statements will be dependent on the magnitude and nature of future acquired entities.
Note 3 — Inventory
Inventory consisted of the following as of May 31, 20222023 and August 31, 2021:2022:
| | | | | | | | | | | | | |
| | | May 31, | | August 31, | | May 31, | | August 31, | ||||
|
|
| 2022 |
| 2021 |
| 2023 |
| 2022 | ||||
Raw materials | | | $ | 36,192 | | $ | 24,055 | | $ | 37,738 | | $ | 37,909 |
Work in process | | | | 7,835 | | | 5,928 | | | 9,561 | | | 9,569 |
Finished goods | | | | 14,524 | | | 11,234 | | | 30,186 | | | 15,561 |
Total Inventory | | | $ | 58,551 | | $ | 41,217 | | $ | 77,485 | | $ | 63,039 |
13
Note 4 — Net Income Per Share
The Company has unvested share-based payment awards with a right to receive nonforfeitable dividends which are considered participating securities under ASCAccounting Standards Codification (ASC) Topic 260, “Earnings Per Share.” The Company allocates earnings to participating securities and computes earnings per share using the two-class method. The determination of earnings per share under the two-class method is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | Three Months Ended May 31, | | | Nine Months Ended May 31, |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, |
| ||||||||||||||||
|
| 2022 |
| 2021 |
| | 2022 |
| 2021 |
|
| 2023 |
| 2022 |
| | 2023 |
| 2022 |
| ||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic Earnings per Share | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net income |
| $ | 15,545 |
| $ | 14,289 |
| | $ | 34,398 |
| $ | 34,297 | |
| $ | 12,092 |
| $ | 15,545 |
| | $ | 27,319 |
| $ | 34,398 | |
Less: Allocated to participating securities | | | 104 | | | 94 | | | | 228 | | | 239 | | | | 97 | | | 104 | | | | 227 | | | 228 | |
Net income available to common shareholders |
| $ | 15,441 |
| $ | 14,195 |
| | $ | 34,170 |
| $ | 34,058 | |
| $ | 11,995 |
| $ | 15,441 |
| | $ | 27,092 |
| $ | 34,170 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic weighted average shares outstanding | | | 9,399,231 | | | 9,386,814 | | | | 9,398,778 | | | 9,381,433 | | | | 9,430,065 | | | 9,399,231 | | | | 9,422,783 | | | 9,398,778 | |
Net income per share - Basic |
| $ | 1.64 |
| $ | 1.51 |
| | $ | 3.64 |
| $ | 3.63 | |
| $ | 1.27 |
| $ | 1.64 |
| | $ | 2.88 |
| $ | 3.64 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Diluted Earnings per Share | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net income |
| $ | 15,545 |
| $ | 14,289 |
| | $ | 34,398 |
| $ | 34,297 | |
| $ | 12,092 |
| $ | 15,545 |
| | $ | 27,319 |
| $ | 34,398 | |
Less: Allocated to participating securities | | | 104 | | | 94 | | | | 228 | | | 239 | | | | 97 | | | 104 | | | | 227 | | | 228 | |
Net income available to common shareholders |
| $ | 15,441 |
| $ | 14,195 |
| | $ | 34,170 |
| $ | 34,058 | |
| $ | 11,995 |
| $ | 15,441 |
| | $ | 27,092 |
| $ | 34,170 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic weighted average shares outstanding | | | 9,399,231 | | | 9,386,814 | | | | 9,398,778 | | | 9,381,433 | | | | 9,430,065 | | | 9,399,231 | | | | 9,422,783 | | | 9,398,778 | |
Additional dilutive common stock equivalents | | | 32,028 | | | 48,521 | | | | 36,591 | | | 45,446 | | | | 33,290 | | | 32,028 | | | | 27,885 | | | 36,591 | |
Diluted weighted average shares outstanding | | | 9,431,259 | | | 9,435,335 | | | | 9,435,369 | | | 9,426,879 | | | | 9,463,355 | | | 9,431,259 | | | | 9,450,668 | | | 9,435,369 | |
Net income per share - Diluted |
| $ | 1.64 |
| $ | 1.50 |
| | $ | 3.62 |
| $ | 3.61 | |
| $ | 1.27 |
| $ | 1.64 |
| | $ | 2.87 |
| $ | 3.62 | |
Included in the calculation of dilutive common stock equivalents are the unvested portion of restricted stock and stock options. For the three- and nine-month periods ended May 31, 2022,2023, stock options to purchase 108,39251,213 and 93,869103,531 shares of common stock, respectively, were outstanding but were not included in the calculation of diluted income per share because their inclusion would be anti-dilutive. For the three- and nine-month periods ended May 31, 2021,2022, stock options to purchase 17,947108,392 and 59,34693,869 shares of common stock, respectively, were outstanding but were not included in the calculation of diluted income per share because theirthe inclusion would be anti-dilutive.
14
Note 5 — Stock-Based Compensation
In August 2020, the Board of Directors of the Company approved the fiscal year 2021 Long Term Incentive Plan (“2021 LTIP”) for the executive officers and other members of management. The 2021 LTIP is an equity-based plan with a grant date of September 1, 2020 and contains (a) a restricted stock grant of 8,717 shares in the aggregate (of which 3,798 included a performance-based vesting component and were subject to adjustment as discussed below), with a vesting date of August 31, 2023, and (b) options to purchase 14,845 shares of common stock in the aggregate with an exercise price of $97.57 per share, vesting in 3 equal annual installments ending on August 31, 2023.
Based on the fiscal year 2021 results, 2,633 additional shares of restricted stock were earned and granted subsequent to the end of fiscal year 2021 in accordance with the performance measurement criteria. No further performance-based measurements apply to this award. Compensation expense is being recognized on a ratable basis over the vesting period.
In August 2021, the Board of Directors of the Company approved the fiscal year 2022 Long Term Incentive Plan (“2022 LTIP”) for the executive officers and other members of management. The 2022 LTIP is an equity-based plan with a grant date of September 1, 2021 and contains (a) a restricted stock grant of 9,584 shares in the aggregate (of which 3,304 included a performance-based vesting component and were subject to adjustment as discussed below), with a vesting date of August 31, 2024, and (b) options to purchase 12,942 shares of common stock in the aggregate with an exercise price of $114.50 per share, vesting in three equal annual installments ending on August 31, 2024.
Based on the fiscal year 2022 results, 842 shares of restricted stock were forfeited subsequent to the end of fiscal year 2022 due to not meeting the performance measurement criteria. No further performance-based measurements apply to this award.
In August 2022, the Board of Directors of the Company approved the fiscal year 2023 Long Term Incentive Plan (“2023 LTIP”) for executive officers and other members of management. The 2023 LTIP is an equity-based plan with a grant date of September 1, 2022 and contains the following equity components:
Restricted Shares — (a) a performance and service-based restricted stock grant of 3,30410,580 shares in the aggregate, subject to adjustment based on fiscal 20222023 results, with a vesting date of August 31, 2024.2025. Compensation expense is recognized on a ratable basis over the vesting period based on quarterly probability assessments; and (b) a time-based restricted stock grantgrants of 6,2809,918 shares in the aggregate,and 636 shares, with a vesting datedates of August 31, 2024.2025 and August 31, 2023, respectively. Compensation expense is being recognized on a ratable basis over the vesting period.
In addition to the 2023 LTIP, the Board of Directors approved a retention grant with a grant date of September 1, 2022 of an aggregate of 10,015 shares of time-based restricted stock. Out of the 10,015 shares of time-based restricted stock granted, 2,056 shares are scheduled to vest on March 1, 2023, 3,705 shares are scheduled to vest on September 1, 2023, 1,418 shares are scheduled to vest on August 31, 2024, and 2,836 shares are scheduled to vest on August 31, 2026. Compensation expense is being recognized on a ratable basis over the vesting period.
Stock Options — options to purchase 12,94225,987 shares of common stock in the aggregate with an exercise price of $114.50$88.16 per share. The options will vest in 3three equal annual installments beginning on August 31, 20222023 and ending on August 31, 2024.2025. The options will expire ten years after the grant date. Compensation expense is being recognized over the period of the award consistent with the vesting terms.
RestrictedIn the second quarter of fiscal 2023, restricted stock from fiscal 2020 grants in the amount of 437314 shares was issued to a non-executive member of management and 570is scheduled to vest on August 31, 2025. Additionally, options to purchase 791 shares of common stock were forfeitedawarded to a non-executive member of management in the firstaggregate with an exercise price of $95.00 per share. The options will vest in three annual installments beginning on August 31, 2023 and ending on August 31, 2025. The options will expire ten years after the grant date. Compensation expense is being recognized on a ratable basis over the vesting period.
In the second quarters, respectively, andquarter of fiscal 2023, restricted stock from fiscal 2022 grants of 559 and 298 shares were forfeited in the second and third quarters, respectively,amount of 1,486 shares related to the fiscal 2023 retention grants were forfeited in conjunction with the termination of employment of non-executive members of management of the Company.
In February 2022, the Board of Directors of the Company approved an equity retention agreement with the Treasurer and Chief Financial Officer. Awards under the equity-based retention agreement have a grant date of February 1, 2022 and contain the following equity components: (a) a time-based restricted stock grant of 5,332 shares with a vesting date of January 31, 2025; and (b) options to purchase 14,480 shares of common stock with an exercise price of $94.88 per share. The options will vest on January 31, 2025 and will expire on February 1, 2032. Compensation expense for both the restricted stock and the stock option components of the equity retention agreements is being recognized on a ratable basis over the vesting period.
In February 2022,2023, as part of their standard compensation for board service, non-employee members of the Board of Directors received a total grant of 5,0007,824 shares of restricted stock for service for the period from January 31, 2022February 7, 2023 through January 31, 2023.February 1, 2024. The shares of restricted stock will vest at the conclusion of this service period. Compensation expense for restricted stock is being recognized on a ratable basis over the twelve-monthtwelve-month vesting period.
In the third quarter of fiscal 2023, restricted stock in the amount of 166 shares related to the fiscal 2020 grant were forfeited in conjunction with the termination of employment of a non-executive member of management of the Company.
15
In the third quarter of fiscal 2023, restricted stock in the amount of 1,129 shares was issued to a non-executive member of management, with 565 shares and 564 shares vesting on March 31, 2025 and March 31, 2027, respectively. Compensation expense was recognized on a ratable basis over the vesting period.
Note 6 — Segment Data and Foreign Operations
The Company is organized into 3three reportable operating segments: Adhesives, Sealants and Additives; Industrial Tapes; and Corrosion Protection and Waterproofing. The segments are distinguished by the nature of the products manufactured and how they are delivered to their respective markets.
The Adhesives, Sealants and Additives segment offers innovative and specialized product offerings consisting of both end-use products and intermediates that are used in, or integrated into, another company’s product. Demand for the segment’s product offerings is typically dependent upon general economic conditions. The Adhesives, Sealants and Additives segment leverages the core specialty chemical competencies of the Company and serves diverse markets and applications. The segment sells predominantly into the transportation, appliances, medical, general industrial and environmental market verticals. The segment’s products include moisture protective coatings and cleaners, customized sealant and adhesive systems for electronics, synthesized specialty waxes and polymers, polymeric microspheres, polyurethane dispersions and superabsorbent polymers. Beginning September 1, 2020,2022, the Adhesives, Sealants and Additives segment includes the acquired operations of ABchimie, within the electronic and industrial coatings product lineand beginning February 5, 2021, the acquired operations of ETi,NuCera, within the functional additives product line.
The Industrial Tapes segment features wire and cable materials, specialty tapes and other laminated and coated products. The segment derives its competitive advantage through its proven chemistries, its diverse specialty offerings and the reliability its supply chain offers to end customers. These products are generally used in the assembly of other manufacturers’ products, with demand typically dependent upon general economic conditions. The Industrial Tapes segment sells mostly to established markets, with some exposure to growth opportunities through further development of existing products. Markets served include wire and cable manufacturing, utilities and telecommunications, and electronics packaging. The segment’s offerings include insulating and conducting materials for wire and cable manufacturers,manufacturers; laminated durable papers,papers; laminates for the packaging and industrial laminate markets,markets; custom manufacturing services,services; pulling and detection tapes used in the installation, measurement and location of fiber optic cables and water and natural gas lineslines; and cover tapes essential to delivering semiconductor components via tape-and-reel packaging.
The Corrosion Protection and Waterproofing segment is principally composed of project-oriented product offerings that are primarily sold and used as “Chase” branded products. End markets include new and existing infrastructure projects on oil, gas, water and wastewater pipelines, highways and bridge decks, water and wastewater containment systems, and commercial and industrial structures. The segment’s products include protective coatings for pipeline applications, coating and lining systems for waterproofing and liquid storage applications, adhesives and sealants used in architectural and building envelope waterproofing applications, high-performance polymeric asphalt additives, and expansion joint systems for waterproofing applications in transportation and architectural markets. With sales generally dependent on outdoor project work, the segment experiences highly seasonal sales patterns.
16
The following tables summarize information about the Company’s reportable segments:
| | | | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | ||||||||||
|
| 2022 |
| | 2021 | | | 2022 | |
| 2021 |
|
| ||||
Revenue | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 36,771 | | | $ | 33,861 | | | $ | 99,600 | | | $ | 95,507 | | |
Industrial Tapes | | | 38,329 | | | | 32,249 | | | | 104,420 | | | | 87,085 | | |
Corrosion Protection and Waterproofing | | | 13,519 | | | | 13,483 | | | | 33,562 | | | | 32,624 | | |
Total | | $ | 88,619 | | | $ | 79,593 | | | $ | 237,582 | | | $ | 215,216 | | |
| | | | | | | | | | | | | | | | | |
Income before income taxes | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 12,320 | (a) | | $ | 10,982 | (c) | | $ | 27,719 | (a) | | $ | 31,098 | (c) | |
Industrial Tapes | | | 10,985 | | | | 10,945 | | | | 30,525 | | | | 27,273 | | |
Corrosion Protection and Waterproofing | | | 5,353 | | | | 5,098 | | | | 12,683 | | | | 11,599 | | |
Total for reportable segments | | | 28,658 | | | | 27,025 | | | | 70,927 | | | | 69,970 | | |
Corporate and common costs | | | (9,310) | (b) | | | (9,282) | (c) | | | (26,095) | (b) | | | (25,385) | (c) | |
Total | | $ | 19,348 | | | $ | 17,743 | | | $ | 44,832 | | | $ | 44,585 | | |
| | | | | | | | | | | | | | | | | |
Includes the following costs by segment: | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | | | | | | | | | | | | | | | | |
Interest | | $ | 36 | | | $ | 25 | | | $ | 105 | | | $ | 79 | | |
Depreciation | | | 234 | | | | 255 | | | | 697 | | | | 744 | | |
Amortization | | | 2,541 | | | | 2,715 | | | | 7,939 | | | | 7,931 | | |
| | | | | | | | | | | | | | | | | |
Industrial Tapes | | | | | | | | | | | | | | | | | |
Interest | | $ | 36 | | | $ | 15 | | | $ | 105 | | | $ | 57 | | |
Depreciation | | | 363 | | | | 412 | | | | 1,184 | | | | 1,305 | | |
Amortization | | | 383 | | | | 387 | | | | 1,150 | | | | 1,160 | | |
| | | | | | | | | | | | | | | | | |
Corrosion Protection and Waterproofing | | | | | | | | | | | | | | | | | |
Interest | | $ | 17 | | | $ | 28 | | | $ | 52 | | | $ | 68 | | |
Depreciation | | | 138 | | | | 157 | | | | 385 | | | | 432 | | |
Amortization | | | 1 | | | | 274 | | | | 3 | | | | 475 | | |
| | | | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | ||||||||||
|
| 2023 |
| | 2022 |
| | 2023 | |
| 2022 |
|
| ||||
Revenue | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 55,083 | | | $ | 36,771 | | | $ | 159,370 | | | $ | 99,600 | | |
Industrial Tapes | | | 40,927 | | | | 38,329 | | | | 116,987 | | | | 104,420 | | |
Corrosion Protection and Waterproofing | | | 10,635 | | | | 13,519 | | | | 27,461 | | | | 33,562 | | |
Total | | $ | 106,645 | | | $ | 88,619 | | | $ | 303,818 | | | $ | 237,582 | | |
| | | | | | | | | | | | | | | | | |
Income before income taxes | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 9,523 | (a) | | $ | 12,320 | (d) | | $ | 19,268 | (a), (b) | | $ | 27,719 | (d) | |
Industrial Tapes | | | 12,710 | | | | 10,985 | | | | 36,915 | | | | 30,525 | | |
Corrosion Protection and Waterproofing | | | 3,689 | | | | 5,353 | | | | 8,703 | | | | 12,683 | | |
Total for reportable segments | | | 25,922 | | | | 28,658 | | | | 64,886 | | | | 70,927 | | |
Corporate and common costs | | | (9,774) | (c) | | | (9,310) | (e) | | | (29,146) | (c) | | | (26,095) | (e) | |
Total | | $ | 16,148 | | | $ | 19,348 | | | $ | 35,740 | | | $ | 44,832 | | |
| | | | | | | | | | | | | | | | | |
Includes the following costs by segment: | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | | | | | | | | | | | | | | | | |
Interest | | $ | 2,361 | | | $ | 36 | | | $ | 6,886 | | | $ | 105 | | |
Depreciation | | | 1,583 | | | | 234 | | | | 4,828 | | | | 697 | | |
Amortization | | | 4,940 | | | | 2,541 | | | | 18,716 | | | | 7,939 | | |
| | | | | | | | | | | | | | | | | |
Industrial Tapes | | | | | | | | | | | | | | | | | |
Interest | | $ | — | | | $ | 36 | | | $ | — | | | $ | 105 | | |
Depreciation | | | 293 | | | | 363 | | | | 969 | | | | 1,184 | | |
Amortization | | | — | | | | 383 | | | | 2 | | | | 1,150 | | |
| | | | | | | | | | | | | | | | | |
Corrosion Protection and Waterproofing | | | | | | | | | | | | | | | | | |
Interest | | $ | — | | | $ | 17 | | | $ | — | | | $ | 52 | | |
Depreciation | | | 118 | | | | 138 | | | | 365 | | | | 385 | | |
Amortization | | | 1 | | | | 1 | | | | 3 | | | | 3 | | |
(a) | Includes a $129 loss in the third quarter and a $563 year-to-date loss on the upward adjustment of the performance-based earn out contingent consideration associated with the September 2020 acquisition of ABchimie, $82 and $516 in operations optimization costs related to the move from Woburn, MA to O’Hara Township, PA in the third quarter and year-to-date period, respectively, $0 and $862 loss on impairment/write-off of long-term asset related to the Woburn, MA facility in the third quarter and year-to-date period, respectively, and $331 and $331 loss on impairment/write-off of long-term asset related to the relocation of the Woodlands, TX facility to the new NuCera-related R&D facility in Houston, TX in the third quarter and year-to-date period, respectively |
(b) | Includes $2,200 of purchase accounting inventory adjustment related to the Company’s NuCera business and $2,820 of backlog amortization fully amortized related to the Company’s NuCera business both incurred during the first quarter of the fiscal year |
(c) | Includes $133 and $990 of operations optimization costs in the third quarter and year-to-date period, respectively, related to the Company’s ERP upgrade |
(d) | For 2022, includes $474 gain in the third quarter and a $199 year-to-date gain on the adjustment of the performance-based earn-out contingent consideration associated with the September 2020 acquisition of ABchimie, |
17
Total assets for the Company’s reportable segments as of May 31, 2023 and August 31, 2022 were as follows:
| | | | | | | | |
| | May 31, | | August 31, | | | ||
|
| 2023 |
| 2022 |
|
| ||
Total Assets | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 434,885 | | $ | 153,784 | | |
Industrial Tapes | | | 85,567 | | | 87,751 | | |
Corrosion Protection and Waterproofing | | | 32,012 | | | 33,037 | | |
Total for reportable segments | | | 552,464 | | | 274,572 | | |
Corporate and common assets (a) | | | 64,832 | | | 337,008 | | |
Total | | $ | 617,296 | | $ | 611,580 | | |
(a) | Corporate and common assets at August 31, 2022 include $180,000 in cash drawn from the Company’s revolving credit facility and $70,000 of cash on hand in anticipation of the acquisition of NuCera, which closed on the first day of fiscal year 2023. |
The Company’s products are sold worldwide. Revenue for the three- and nine-month periods ended May 31, 2023 and 2022 was attributed to operations located in the following countries:
| | | | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | ||||||||||
| | 2023 |
| | 2022 | | | 2023 | |
| 2022 | | | ||||
Revenue | | | | | | | | | | | | | | | | | |
United States | | $ | 92,061 | | | $ | 76,140 | | | $ | 259,807 | | | $ | 204,009 | | |
United Kingdom | | | 5,995 | | | | 6,604 | | | | 17,304 | | | | 17,125 | | |
France | | | 5,795 | | | | 2,667 | | | | 18,906 | | | | 7,638 | | |
All other foreign (1) | | | 2,794 | | | | 3,208 | | | | 7,801 | | | | 8,810 | | |
Total | | $ | 106,645 | | | $ | 88,619 | | | $ | 303,818 | | | $ | 237,582 | | |
| | | | | | | | | | | | | | | | | |
(1) | Consists of sales from royalty revenue attributable to its licensed manufacturer in Asia and sales originated from the Company’s foreign operations in China, India and Singapore. |
18
Total assets for the Company’s reportable segments as of May 31, 2022 and August 31, 2021 were:
| | | | | | | | |
| | May 31, | | August 31, | | | ||
|
| 2022 |
| 2021 |
|
| ||
Total Assets | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 156,385 | | $ | 161,968 | | |
Industrial Tapes | | | 85,264 | | | 72,301 | | |
Corrosion Protection and Waterproofing | | | 33,447 | | | 31,067 | | |
Total for reportable segments | | | 275,096 | | | 265,336 | | |
Corporate and common assets | | | 145,795 | | | 138,823 | | |
Total | | $ | 420,891 | | $ | 404,159 | | |
The Company’s products are sold worldwide. Revenue for the three- and nine-month periods ended May 31, 2022 and 2021 was attributed to operations located in the following countries:
| | | | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | ||||||||||
| | 2022 |
| | 2021 | | | 2022 | |
| 2021 | | | ||||
Revenue | | | | | | | | | | | | | | | | | |
United States | | $ | 76,140 | | | $ | 67,264 | | | $ | 204,009 | | | $ | 178,635 | | |
United Kingdom | | | 6,604 | | | | 6,184 | | | | 17,125 | | | | 19,208 | | |
All other foreign (1) | | | 5,875 | | | | 6,145 | | | | 16,448 | | | | 17,373 | | |
Total | | $ | 88,619 | | | $ | 79,593 | | | $ | 237,582 | | | $ | 215,216 | | |
| | | | | | | | | | | | | | | | | |
As of May 31, 20222023 and August 31, 20212022 the Company had long-lived assets (defined as tangible assets providing the Company with a future economic benefit beyond the current year or operating period, including buildings, equipment and leasehold improvements) and goodwill and intangible assets, less accumulated amortization, in the following countries:
| | | | | | | | | | | | | | | ||
| | May 31, | | August 31, | | | | May 31, | | August 31, | | | ||||
| | 2022 |
| 2021 | | | | 2023 |
| 2022 | | | ||||
Long-Lived Assets | | | | | | | | | | | | | | | ||
United States | | | | | | | | | | | | | | | | |
Property, plant and equipment, net | | $ | 21,385 | | $ | 20,990 | | | | $ | 58,950 | | $ | 21,300 | | |
Goodwill and Intangible assets, less accumulated amortization | | | 107,633 | | | 115,936 | | | | | 307,636 | | | 105,216 | | |
| | | | | | | | | | | | | | | | |
United Kingdom | | | | | | | | | | | | | | | | |
Property, plant and equipment, net | | | 2,050 | | | 2,174 | | | | | 1,786 | | | 1,832 | | |
Goodwill and Intangible assets, less accumulated amortization | | | 3,589 | | | 3,905 | | | | | 3,516 | | | 3,318 | | |
| | | | | | | | | | | | | | | | |
France | | | | | | | | | ||||||||
Property, plant and equipment, net | | | 314 | | | 239 | | | ||||||||
Goodwill and Intangible assets, less accumulated amortization | | | 29,885 | | | 20,130 | | | ||||||||
| | | | | | | | | ||||||||
All other foreign | | | | | | | | | | | | | | | | |
Property, plant and equipment, net | | | 1,096 | | | 1,103 | | | | | 868 | | | 877 | | |
Goodwill and Intangible assets, less accumulated amortization | | | 22,046 | | | 24,979 | | | | | 653 | | | 157 | | |
| | | | | | | | | | | | | | | | |
Total | | | | | | | | | | | | | | | | |
Property, plant and equipment, net | | $ | 24,531 | | $ | 24,267 | | | | $ | 61,918 | | $ | 24,248 | | |
Goodwill and Intangible assets, less accumulated amortization | | $ | 133,268 | | $ | 144,820 | | | | $ | 341,690 | | $ | 128,821 | | |
1819
Note 7 — Goodwill and Other Intangibles
The changes in the carrying value of goodwill were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Adhesives, Sealants and Additives |
| Industrial Tapes |
| Corrosion Protection and Waterproofing |
| Consolidated |
|
| Adhesives, Sealants and Additives |
| Industrial Tapes |
| Corrosion Protection and Waterproofing |
| Consolidated |
| ||||||||
Balance at August 31, 2021 | | $ | 65,945 | | $ | 21,215 | | $ | 10,706 | | $ | 97,866 | | |||||||||||||
Balance at August 31, 2022 | | $ | 63,272 | | $ | 21,215 | | $ | 10,673 | | $ | 95,160 | | |||||||||||||
Acquisition of NuCera Solutions | | | 81,349 | | | — | | | — | | | 81,349 | | |||||||||||||
Foreign currency translation adjustment | | | (1,527) | | | — | | | (18) | | | (1,545) | | | | 1,216 | | | — | | | 11 | | | 1,227 | |
Balance at May 31, 2022 | | $ | 64,418 | | $ | 21,215 | | $ | 10,688 | | $ | 96,321 | | |||||||||||||
Balance at May 31, 2023 | | $ | 145,837 | | $ | 21,215 | | $ | 10,684 | | $ | 177,736 | | |||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | |
The Company’s goodwill is allocated to each reporting unit based on the nature of the products manufactured by the respective business combinations that originally created the goodwill. The Company has identified a total of 3three reporting units, corresponding to its 3three operating segments, that are used to evaluate the possible impairment of goodwill. Assessments of possible impairment of goodwill are made when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable through future operations. Additionally, testing for possible impairment of recorded goodwill and certain intangible asset balances is required annually.annually or more frequently if impairment indicators occur. The amount and timing of any impairment charges based on these assessments require the estimation of future cash flows and the fair market value of the related assets based on management’s best estimates of certain key factors, including future selling prices and volumes; operating, raw material and energy costs; and various other projected operating and economic factors, including the anticipated future impact of thecoronavirus disease 2019 (COVID-19) pandemic.factors. When testing, fair values of the reporting units are established using discounted cash flows. The Company evaluates the possible impairment of goodwill annually during the fourth quarter, and whenever events or circumstances indicate the carrying value of goodwill may not be recoverable.
The Company has adopted ASUAccounting Standards Update (ASU) No. 2017-04 “Intangibles - Goodwill and Other Topics (Topic 350): Simplifying the Test for Goodwill Impairment.” The Company assesses goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount. If the fair value of a reporting unit is less than its carrying value, an impairment loss, limited to the amount of goodwill allocated to that reporting unit, is recorded.
Intangible assets subject to amortization consisted of the following as of May 31, 20222023 and August 31, 2021:2022:
| | | | | | | | | | | | | | | | | | �� | | | | | | |
| | Weighted Average | | Gross Carrying | | Accumulated | | Net Carrying | | | Weighted Average | | Gross Carrying | | Accumulated | | Net Carrying | | ||||||
|
| Amortization Period |
| Value |
| Amortization |
| Value |
|
| Amortization Period |
| Value |
| Amortization |
| Value |
| ||||||
May 31, 2022 | | | | | | | | | | | | | ||||||||||||
May 31, 2023 | | | | | | | | | | | | | ||||||||||||
Patents and agreements | | 14.6 | years | $ | 1,760 | | $ | 1,722 | | $ | 38 | | | 14.6 | years | $ | 1,760 | | $ | 1,731 | | $ | 29 | |
Formulas and technology | | 7.8 | years | | 10,844 | | | 9,989 | | | 855 | | | 7.9 | years | | 24,223 | | | 11,428 | | | 12,795 | |
Trade names | | 5.9 | years | | 8,747 | | | 8,435 | | | 312 | | | 6.3 | years | | 14,830 | | | 9,207 | | | 5,623 | |
Customer lists and relationships | | 9.1 | years | | 115,102 | | | 79,360 | | | 35,742 | | | 11.0 | years | | 243,847 | | | 98,340 | | | 145,507 | |
| | | | $ | 136,453 | | $ | 99,506 | | $ | 36,947 | | | | | $ | 284,660 | | $ | 120,706 | | $ | 163,954 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
August 31, 2021 | | | | | | | | | | | | | ||||||||||||
August 31, 2022 | | | | | | | | | | | | | ||||||||||||
Patents and agreements | | 14.6 | years | $ | 1,760 | | $ | 1,715 | | $ | 45 | | | 14.6 | years | $ | 1,760 | | $ | 1,724 | | $ | 36 | |
Formulas and technology | | 7.9 | years | | 10,987 | | | 9,769 | | | 1,218 | | | 7.8 | years | | 10,730 | | | 9,961 | | | 769 | |
Trade names | | 5.9 | years | | 8,836 | | | 8,285 | | | 551 | | | 5.9 | years | | 8,673 | | | 8,407 | | | 266 | |
Customer lists and relationships | | 9.2 | years | | 116,855 | | | 71,715 | | | 45,140 | | | 9.1 | years | | 113,735 | | | 81,145 | | | 32,590 | |
| | | | $ | 138,438 | | $ | 91,484 | | $ | 46,954 | | | | | $ | 134,898 | | $ | 101,237 | | $ | 33,661 | |
1920
Aggregate amortization expense related to intangible assets for the nine months ended May 31, 2023 and 2022 was $18,721 and 2021 was $9,092 and $9,566, respectively. Estimated amortization expense for the remainder of fiscal year 20222023 and for the next five years is as follows:
| | | | | | | | |
Years ending August 31, |
| | | |
| | | |
2022 (remaining 3 months) | | $ | 2,669 |
| ||||
2023 | | | 8,612 | | ||||
2023 (remaining 3 months) | | | 4,937 | | ||||
2024 | | | 7,405 | | | | 19,649 | |
2025 | | | 5,805 | | | | 18,049 | |
2026 | | | 5,007 | | | | 17,252 | |
2027 | | | 2,460 | | | | 14,704 | |
2028 | | | 14,086 | |
Note 8 — Leases
The Company accounts for leases in accordance towith ASU 2016-02, “Leases (Topic 842).” At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (ROU) assets and short-term and long-term lease liabilities, as applicable. The Company does not have any financing leases that are material in nature.
Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company believes it could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.
The Company has elected not to recognize leases with an original term of one year or less on the balance sheet. The Company typically only includes an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in the Company’s assessment unless there is reasonable certainty that the Company will renew.
During the third quarter of 2023, Chase moved out of the Woodlands, TX facility (previously NuCera Corporate and R&D headquarters) to a smaller R&D facility in Houston, TX. On the last day of the third fiscal quarter, the Company signed a sublease agreement for the Woodlands office and expensed $211 as a lease impairment related to this facility in the third quarter of the fiscal period. The project is now substantially complete, and any future costs related to the facility relocation are not anticipated to be significant to the condensed consolidated financial statements.
The Company wrote-off $120 of fixed assets primarily related to the R&D relocation of the Houston, TX facility in the third quarter and year-to-date period of fiscal 2023. The total third quarter and year-to-date expense related to the move of $331 is included in the Loss on impairment/write-off of long-term asset in the Condensed Consolidated Statement of Operations. The project is now substantially complete and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.
On the last day of the second fiscal quarter, the Company signed a termination agreement for the Woburn, MA facility and wrote off the right-of-use asset and liability of the Woburn, MA lease, expensing $314 in the second fiscal quarter of 2023. Additionally, the Company expensed $548 as a lease impairment related to the Woburn, MA facility in the first quarter of fiscal 2023.
The Company’s total combined year-to-date expense of $1,193 is included in the Loss on impairment/write-off of long-term assets in the Condensed Consolidated Statement of Operations.
21
The following table presents the right-of-use asset and short-term and long-term lease liabilities amounts recorded on the condensed consolidated balance sheet as of May 31, 20222023 and August 31, 2021:2022:
| | | | | | | | | | | | |
| | May 31, | | August 31, | | May 31, | | August 31, | ||||
| | 2022 | | 2021 | | 2023 | | 2022 | ||||
Assets |
| | |
| | |
| | |
| | |
Operating lease right-of-use asset | | $ | 9,078 | | $ | 9,312 | ||||||
Operating lease right-of-use assets | | $ | 7,341 | | $ | 8,596 | ||||||
| | | | | | | | | | | | |
Liabilities | | | | | | | | | | | | |
Current (accrued expenses) | | $ | 1,466 | | $ | 1,515 | | $ | 1,507 | | $ | 1,448 |
Operating lease long-term liabilities | | | 7,060 | | | 7,202 | | | 5,449 | | | 6,618 |
Total lease liability | | $ | 8,526 | | $ | 8,717 | | $ | 6,956 | | $ | 8,066 |
| | | | | | | | | | | | |
2022
Lease costCost
The components of lease costs for the three and nine months ended May 31, 20222023 and 20212022 are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | Nine Months Ended May 31, | | Three Months Ended May 31, | | | Nine Months Ended May 31, | |||||||||||||||||
| | 2022 | | 2021 | | 2022 | | 2021 | | 2023 | | 2022 |
| | 2023 | | 2022 | |||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating lease cost (a) | | $ | 790 | | $ | 911 | | $ | 2,451 | | $ | 2,833 | | $ | 1,002 | | $ | 790 | | | $ | 3,045 | | $ | 2,451 |
(a) | Includes short-term leases and variable lease costs (e.g. common area maintenance), which are immaterial. |
Maturity of lease liabilityLease Liability
The maturity of the Company's lease liabilities at May 31, 20222023 was as follows:
| | | |
| | Future Operating | |
Year ending August 31, |
| Lease Payments | |
2022 (remaining 3 months) | | | 427 |
2023 | | | 1,677 |
2024 | | | 1,602 |
2025 | | | 1,444 |
2026 | | | 1,182 |
2027 and thereafter | | | 3,002 |
Less: Interest | | | (808) |
Present value of lease liabilities | | $ | 8,526 |
| | | | |
| | Future Operating | | |
Year ending August 31, |
| Lease Payments |
| |
2023 (remaining 3 months) | | | 435 | |
2024 | | | 1,656 | |
2025 | | | 1,432 | |
2026 | | | 1,099 | |
2027 | | | 737 | |
2028 and thereafter | | | 2,226 | |
Less: Interest | | | (629) | |
Present value of lease liabilities | | $ | 6,956 | |
The weighted average remaining lease termterms and discount rates are as follows:
| | | | | | | | | | | | | | |
| | May 31, | | August 31, | | | May 31, | | August 31, | | ||||
| | 2022 | | 2021 | | | 2023 | | 2022 | | ||||
Lease Term and Discount Rate |
| | |
| | | |
| | |
| | | |
Weighted average remaining lease term (years) | | | | | | | | |||||||
Weighted average remaining lease terms (years) | | | | | | | | |||||||
Operating leases | | | 6.7 | | | 6.8 | | | | 6.0 | | | 6.5 | |
Weighted average discount rate (percentage) | | | | | | | | | | | | | | |
Operating leases | | | 2.8 | % | | 3.1 | % | | | 3.2 | % | | 2.8 | % |
Other Information
Supplemental cash flow information related to leases included in the balance sheet is as follows:
| | | | | | | | | | | | |
| | Nine Months Ended May 31, | | Nine Months Ended May 31, | ||||||||
| | 2022 | | 2021 | | 2023 | | 2022 | ||||
| | | | | | | | | | | | |
Operating cash outflows from operating leases | | $ | 1,311 | | $ | 1,797 | | $ | 2,183 | | $ | 1,311 |
Total cash paid for amounts included in the measurement of lease liabilities | | $ | 1,311 | | $ | 1,797 | | $ | 2,183 | | $ | 1,311 |
2123
Note 9 — Revenue from Contracts with Customers
The Company accounts for revenue in accordance with ASC 606, “Revenue from Contracts with Customers.” The Company’s revenue is generated from the manufacture of specialty chemical products including coatings, linings, adhesives, sealants, specialty tapes, polymers and laminates. Certain of these manufactured products can incorporate customer-owned materials. The Company also recognizes, to a lesser extent, revenue through royalties and commissions from licensed manufacturers and from providing custom manufacturing-related services. The Company’s revenue recognition policies require the Company to make significant judgments and estimates. In applying the Company’s revenue recognition policy, determinations must be made as to when control of products passes to the Company’s customers, which can be either at a point in time or over time based on contractual terms with customers. Revenue is generally recognized at a point in time when control passes upon either shipment to or receipt by the customer of the Company’s products, while revenue is generally recognized over time when control of the Company’s products transfers to customers during the manufacturing process.The Company analyzes several factors, including but not limited to the nature of the products being sold and contractual terms and conditions in contracts with customers, to help the Company make such judgments about revenue recognition.
Contract Balances
The Company’s contract assets primarily relate to unbilled revenue for products currently in production at the Company’s facilities and which incorporate customer-owned material. Revenue is recognized in advance of billing to the customer in these specific circumstances, whereas billing is typically performed at the time of shipment to or receipt by the customer.
Contract assets are included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheet. The following table presents contract assets by reportable operating segment as of May 31, 20222023 and August 31, 2021:2022:
| | | | | | | | | | | | |
| | May 31, | | August 31, | | May 31, | | August 31, | ||||
|
| 2022 |
| 2021 |
| 2023 |
| 2022 | ||||
Contract Assets | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 27 | | $ | 21 | | $ | 46 | | $ | 55 |
Industrial Tapes | | | 75 | | | 82 | | | 372 | | | 123 |
Corrosion Protection and Waterproofing | | | 102 | | | 25 | | | 23 | | | 3 |
Total | | $ | 204 | | $ | 128 | | $ | 441 | | $ | 181 |
The Company did 0tnot have any contract liabilities as of May 31, 20222023 and August 31, 2021.2022.
2224
Disaggregated Revenue
The Company disaggregates revenue from customers by geographic region, as it believes this disclosure best depicts how the nature, amount, timing and uncertainty of the Company's revenue and cash flows are affected by economic factors. Disaggregated revenue by geographical region for the three and nine months ended May 31, 20222023 and 20212022 was as follows:
| | | | | | | | | | | | | | | ||||||||||||||
| | Three Months Ended May 31, 2022 | ||||||||||||||||||||||||||
| | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | ||||||||||||||||||
| | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | ||||||||||||||||||
Revenue | | | | | | | | | | | | | | | ||||||||||||||
North America | | $ | 24,015 | | $ | 34,044 | | | $ | 11,728 | | | $ | 69,787 | ||||||||||||||
Asia\Middle East | | | 6,143 | | | 2,103 | | | | 1,121 | | | | 9,367 | ||||||||||||||
Europe | | | 6,362 | | | 1,373 | | | | 654 | | | | 8,389 | ||||||||||||||
All other foreign | | | 251 | | | 809 | | | | 16 | | | | 1,076 | ||||||||||||||
Total Revenue | | $ | 36,771 | | $ | 38,329 | | | $ | 13,519 | | | $ | 88,619 | ||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Nine Months Ended May 31, 2022 | | Three Months Ended May 31, 2023 | ||||||||||||||||||||||||
| | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | ||||||||
| | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | ||||||||
Revenue | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
North America | | $ | 62,992 | | $ | 93,321 | | | $ | 28,932 | | | $ | 185,245 | | $ | 30,416 | | $ | 37,096 | | | $ | 9,470 | | | $ | 76,982 |
Asia\Middle East | | | 19,292 | | | 5,682 | | | | 2,547 | | | | 27,521 | | | 12,557 | | | 1,456 | | | | 459 | | | | 14,472 |
Europe | | | 16,733 | | | 3,734 | | | | 2,019 | | | | 22,486 | | | 11,697 | | | 1,721 | | | | 556 | | | | 13,974 |
All other foreign | | | 583 | | | 1,683 | | | | 64 | | | | 2,330 | | | 413 | | | 654 | | | | 150 | | | | 1,217 |
Total Revenue | | $ | 99,600 | | $ | 104,420 | | | $ | 33,562 | | | $ | 237,582 | | $ | 55,083 | | $ | 40,927 | | | $ | 10,635 | | | $ | 106,645 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended May 31, 2021 | | Nine Months Ended May 31, 2023 | ||||||||||||||||||||||||
| | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | ||||||||
| | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | ||||||||
Revenue | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
North America | | $ | 20,497 | | $ | 28,620 | | | $ | 11,631 | | | $ | 60,748 | | $ | 84,908 | | $ | 104,134 | | | $ | 23,923 | | | $ | 212,965 |
Asia\Middle East | | | 7,030 | | | 2,019 | | | | 1,023 | | | | 10,072 | | | 38,692 | | | 5,334 | | | | 1,989 | | | | 46,015 |
Europe | | | 6,167 | | | 1,009 | | | | 746 | | | | 7,922 | | | 34,815 | | | 5,561 | | | | 1,323 | | | | 41,699 |
All other foreign | | | 167 | | | 601 | | | | 83 | | | | 851 | | | 955 | | | 1,958 | | | | 226 | | | | 3,139 |
Total Revenue | | $ | 33,861 | | $ | 32,249 | | | $ | 13,483 | | | $ | 79,593 | | $ | 159,370 | | $ | 116,987 | | | $ | 27,461 | | | $ | 303,818 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Nine Months Ended May 31, 2021 | | Three Months Ended May 31, 2022 | ||||||||||||||||||||||||
| | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | ||||||||
| | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | ||||||||
Revenue | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
North America | | $ | 56,606 | | $ | 76,429 | | | $ | 27,062 | | | $ | 160,097 | | $ | 24,015 | | $ | 34,044 | | | $ | 11,728 | | | $ | 69,787 |
Asia\Middle East | | | 21,958 | | | 5,855 | | | | 3,592 | | | | 31,405 | | | 6,143 | | | 2,103 | | | | 1,121 | | | | 9,367 |
Europe | | | 16,497 | | | 3,061 | | | | 1,823 | | | | 21,381 | | | 6,362 | | | 1,373 | | | | 654 | | | | 8,389 |
All other foreign | | | 446 | | | 1,740 | | | | 147 | | | | 2,333 | | | 251 | | | 809 | | | | 16 | | | | 1,076 |
Total Revenue | | $ | 95,507 | | $ | 87,085 | | | $ | 32,624 | | | $ | 215,216 | | $ | 36,771 | | $ | 38,329 | | | $ | 13,519 | | | $ | 88,619 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Nine Months Ended May 31, 2022 | ||||||||||||||||||||||||||
| | Adhesives, Sealants | | Industrial | | | Corrosion Protection | | | Consolidated | ||||||||||||||||||
| | and Additives |
| Tapes | | | and Waterproofing | | | Revenue | ||||||||||||||||||
Revenue | | | | | | | | | | | | | | | ||||||||||||||
North America | | $ | 62,992 | | $ | 93,321 | | | $ | 28,932 | | | $ | 185,245 | ||||||||||||||
Asia\Middle East | | | 19,292 | | | 5,682 | | | | 2,547 | | | | 27,521 | ||||||||||||||
Europe | | | 16,733 | | | 3,734 | | | | 2,019 | | | | 22,486 | ||||||||||||||
All other foreign | | | 583 | | | 1,683 | | | | 64 | | | | 2,330 | ||||||||||||||
Total Revenue | | $ | 99,600 | | $ | 104,420 | | | $ | 33,562 | | | $ | 237,582 |
2325
Note 10 — Commitments and Contingencies
The Company is involved from time to time in litigation incidental to the conduct of its business. Although the Company does not expect that the outcome in any of these matters, individually or collectively, will have a material adverse effect on its financial condition, results of operations or cash flows, litigation is inherently unpredictable. Therefore, judgments could be rendered, or settlements agreed to that could adversely affect the Company’s operating results or cash flows in a particular period. The Company routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.
Note 11 — Pensions and Other Postretirement Benefits
The components of net periodic benefit cost for the three and nine months ended May 31, 20222023 and 20212022 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | | Nine Months Ended May 31, | | | | Three Months Ended May 31, | | | Nine Months Ended May 31, | ||||||||||||||||
|
| 2022 |
| 2021 |
| | 2022 |
| 2021 |
|
|
| 2023 |
| 2022 |
| | 2023 |
| 2022 | ||||||||
Components of net periodic benefit cost | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Service cost | | $ | 95 | | $ | 91 | | | $ | 285 | | $ | 274 | | | | $ | 58 | | $ | 95 | | | $ | 206 | | $ | 285 |
Interest cost | | | 96 | | | 86 | | | | 288 | | | 256 | | | | | 143 | | | 96 | | | | 469 | | | 288 |
Expected return on plan assets | | | (103) | | | (97) | | | | (309) | | | (293) | | | | | (91) | | | (103) | | | | (278) | | | (309) |
Amortization of prior service cost | | | 1 | | | 1 | | | | 3 | | | 3 | | | | | 1 | | | 1 | | | | 3 | | | 3 |
Amortization of accumulated loss | | | 148 | | | 164 | | | | 444 | | | 492 | | | | | 85 | | | 148 | | | | 368 | | | 444 |
Curtailment and settlement loss | | | (90) | | | — | | | | 211 | | | — | |||||||||||||||
Net periodic benefit cost | | $ | 237 | | $ | 245 | | | $ | 711 | | $ | 732 | | | | $ | 106 | | $ | 237 | | | $ | 979 | | $ | 711 |
When funding is required, the Company’s policy is to contribute amounts that are deductible for federal income tax purposes. The Company has made contributions of $1,5261,173 in the nine months ended May 31, 20222023 to fund its obligations under its pension plans, and plans to make the necessary contributions over the remainder of fiscal 20222023 to ensure the qualified plan continues to be adequately funded given the current market conditions, including conditions related to the coronavirus disease 2019 (COVID-19) pandemic.conditions. The Company made contributions of $1,174$1,526 in the nine months ended May 31, 2021.2022.
2426
Note 12 — Fair Value Measurements
The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three-tier fair value hierarchy, which classifies the inputs used in measuring fair values. These tiers are: Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
The Company utilizes the best available information in measuring fair value. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The financial assets classified as Level 1 and Level 2 as of May 31, 2022 and August 31, 2021 represent investments that are restricted for use in nonqualified retirement savings plans for certain key employees and directors.
The following table sets forth the Company’s financial assets that were accounted for at fair value on a recurring basis as of May 31, 20222023 and August 31, 2021:2022:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | Fair value measurement category | | | | | | | | Fair value measurement category | | ||||||||||||||
| | | | | | | Quoted prices | | Significant other | | Significant | | | | | | | | Quoted prices | | Significant other | | Significant | | ||||||
| | Fair value | | | | | in active markets | | observable inputs | | unobservable inputs | | | Fair value | | | | | in active markets | | observable inputs | | unobservable inputs | | ||||||
|
| measurement date |
| Total |
| (Level 1) |
| (Level 2) |
| (Level 3) |
|
| measurement date |
| Total |
| (Level 1) |
| (Level 2) |
| (Level 3) |
| ||||||||
Assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Restricted investments | | May 31, 2022 | | $ | 2,312 | | $ | 2,070 | | $ | 242 | | $ | — | | | May 31, 2023 | | $ | 2,672 | | $ | 2,437 | | $ | 235 | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Restricted investments | | August 31, 2021 | | $ | 2,260 | | $ | 2,016 | | $ | 244 | | $ | — | | | August 31, 2022 | | $ | 2,367 | | $ | 2,125 | | $ | 242 | | $ | — | |
The financial assets classified as Level 1 and Level 2 as of May 31, 2023 and August 31, 2022 represent investments that are restricted for use in nonqualified retirement savings plans for certain key employees and directors.
The following table presents the fair value of the Company’s liabilities that are accounted for at fair value on a recurring basis as of May 31, 20222023 and August 31, 2021:2022:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | Fair value measurement category | | | | | | | | Fair value measurement category | | ||||||||||||||
| | | | | | | Quoted prices | | Significant other | | Significant | | | | | | | | Quoted prices | | Significant other | | Significant | | ||||||
| | Fair value | | | | | in active markets | | observable inputs | | unobservable inputs | | | Fair value | | | | | in active markets | | observable inputs | | unobservable inputs | | ||||||
|
| measurement date |
| Total |
| (Level 1) |
| (Level 2) |
| (Level 3) |
|
| measurement date |
| Total |
| (Level 1) |
| (Level 2) |
| (Level 3) |
| ||||||||
Liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Long-term debt | | May 31, 2022 | | $ | — | | $ | — | | $ | — | | $ | — | | | May 31, 2023 | | $ | 130,000 | | $ | — | | $ | 130,000 | | $ | — | |
Contingent consideration | | May 31, 2022 | | $ | 2,099 | | $ | — | | $ | — | | $ | 2,099 | | | May 31, 2023 | | $ | 3,342 | | $ | — | | $ | — | | $ | 3,342 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Long-term debt | | August 31, 2021 | | $ | — | | $ | — | | $ | — | | $ | — | | | August 31, 2022 | | $ | 180,000 | | $ | — | | $ | 180,000 | | $ | — | |
Contingent consideration | | August 31, 2021 | | $ | 2,537 | | $ | — | | $ | — | | $ | 2,537 | | | August 31, 2022 | | $ | 2,584 | | $ | — | | $ | — | | $ | 2,584 | |
The long-term debt (including any current portion of long-term debt) had 0 outstandinga $130,000 and $180,000 balance as of May 31, 20222023 and August 31, 2021.2022, respectively. The carrying value of the long-term debt approximates its fair value and has a weighted average interest rate of 6.6% as theof May 31, 2023. The interest rate is set based on the movement of the underlying market rates. See Note 16 to the condensed consolidated financial statements for additional information on long-term debt.
In connection with accounting for the ABchimie acquisition on September 1, 2020 (fiscal 2021), the Company recorded a contingent consideration liability included within Other liabilities on the condensed consolidated balance sheet of €780 (approximately $928) on the acquisition date, representing the fair value of contingent consideration payable upon the achievement of a performance-based target. The contingent consideration liability was valued using a Monte Carlo simulation model in an option pricing framework based on key inputs that are not all observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The Company assesses the fair value of the contingent consideration liability at each reporting period. Any subsequent changes in the estimated fair value of the liability are reflected in Loss (gain)(Gain) on contingent consideration on the condensed consolidated statement of operations until the liability is settled. As of May 31, 2022,2023, the liability decreasedincreased to $2,099$3,342 predominantly due to changes in non-market data assumptions as well as a shorter period to the payment date.See Note 17 to the condensed consolidated financial statements for additional information on the acquisition of ABchimie.
2527
Note 13 — Accumulated Other Comprehensive Income
The changes in accumulated other comprehensive income (loss), net of tax, were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Change in Funded | | Foreign Currency | | | | | | | | | Change in Funded | | Foreign Currency | | | | | ||||
| | Restricted | | Status of | | Translation | | | | | | Restricted | | Status of | | Translation | | | | | ||||||
|
| Investments |
| Pension Plans |
| Adjustment |
| Total |
|
| Investments |
| Pension Plans |
| Adjustment |
| Total |
| ||||||||
Balance at August 31, 2020 | | $ | 269 | | $ | (8,317) | | $ | (5,044) | | $ | (13,092) | | |||||||||||||
Balance at August 31, 2021 | | $ | 518 | | $ | (7,979) | | $ | (3,749) | | $ | (11,210) | | |||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Other comprehensive gains (losses) before reclassifications (1) | | | 226 | | | — | | | 3,273 | | | 3,499 | | | | (213) | | | — | | | (5,174) | | | (5,387) | |
Reclassifications to net income of previously deferred (gains) losses (2) | | | (40) | | | 371 | | | — | | | 331 | | | | (64) | | | 336 | | | — | | | 272 | |
Other comprehensive income (loss) | | | 186 | | | 371 | | | 3,273 | | | 3,830 | | | | (277) | | | 336 | | | (5,174) | | | (5,115) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at May 31, 2021 | | $ | 455 | | $ | (7,946) | | $ | (1,771) | | $ | (9,262) | | |||||||||||||
Balance at May 31, 2022 | | $ | 241 | | $ | (7,643) | | $ | (8,923) | | $ | (16,325) | | |||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at August 31, 2021 | | $ | 518 | | $ | (7,979) | | $ | (3,749) | | $ | (11,210) | | |||||||||||||
Balance at August 31, 2022 | | $ | 164 | | $ | (7,200) | | $ | (13,331) | | $ | (20,367) | | |||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Other comprehensive gains (losses) before reclassifications (3) | | | (213) | | | — | | | (5,174) | | | (5,387) | | | | 78 | | | — | | | 4,064 | | | 4,142 | |
Reclassifications to net income of previously deferred (gains) losses (4) | | | (64) | | | 336 | | | — | | | 272 | | | | (74) | | | 437 | | | — | | | 363 | |
Other comprehensive income (loss) | | | (277) | | | 336 | | | (5,174) | | | (5,115) | | | | 4 | | | 437 | | | 4,064 | | | 4,505 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance at May 31, 2022 | | $ | 241 | | $ | (7,643) | | $ | (8,923) | | $ | (16,325) | | |||||||||||||
Balance at May 31, 2023 | | $ | 168 | | $ | (6,763) | | $ | (9,267) | | $ | (15,862) | |
(1) | Net of tax |
(2) | Net of tax expense of |
(3) | Net of tax |
(4) | Net of tax expense of |
The following table summarizes the reclassifications from accumulated other comprehensive income (loss) to the unaudited condensed consolidated statements of income:
| | | | | | | | | | | | | | | | | ||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | Location of Gain (Loss) | | ||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | Reclassified from | | |||||||||||
| | | | | Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive | | | | | | | | Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive | | Accumulated | | ||||||||||||||||||||||
| | | | | Income (Loss) into Income | | | | | | | | Income (Loss) into Income | | Other Comprehensive | | ||||||||||||||||||||||
| | | | | Three Months Ended May 31, | | | Nine Months Ended May 31, | | Location of Gain (Loss) Reclassified from Accumulated | | | | | | Three Months Ended May 31, | | | Nine Months Ended May 31, | | Income (Loss) | | ||||||||||||||||
|
|
|
| | 2022 |
| 2021 |
|
| 2022 |
| 2021 | | Other Comprehensive Income (Loss) into Income |
|
|
|
| | 2023 |
| 2022 |
|
| 2023 |
| 2022 | | into Income |
| ||||||||
Gains on Restricted Investments: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||
Realized loss (gain) on sale of restricted investments | | | | | $ | (6) | | $ | (5) | | | $ | (86) | | $ | (54) | | Selling, general and administrative expenses | | | | | | $ | (10) | | $ | (6) | | | $ | (100) | | $ | (86) | | Selling, general and administrative expenses | |
Tax expense (benefit) | | | | | | 1 | | | 1 | | | | 22 | | | 14 | | | | | | | | | 3 | | | 1 | | | | 26 | | | 22 | | | |
Gain net of tax | | | | | $ | (5) | | $ | (4) | | $ | (64) | | $ | (40) | | | | | | | | $ | (7) | | $ | (5) | | | $ | (74) | | $ | (64) | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||||
Loss on Funded Pension Plan adjustments: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||||
Amortization of prior pension service costs and unrecognized losses | | | | | | 149 | | 165 | | | | 447 | | 495 | | Other income (expense) | | | | | | | 86 | | 149 | | | | 371 | | 447 | | Other (expense) income | | ||||
Settlement and curtailment loss | | | | | | (90) | | — | | | | 211 | | — | | Other (expense) income | | |||||||||||||||||||||
Tax expense (benefit) | | | | | | (37) | | | (41) | | | | (111) | | | (124) | | | | | | | | | 1 | | | (37) | | | | (145) | | | (111) | | | |
Loss net of tax | | | | | $ | 112 | | $ | 124 | | $ | 336 | | $ | 371 | | | | | | | | $ | (3) | | $ | 112 | | | $ | 437 | | $ | 336 | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total net loss reclassified for the period | | | | | $ | 107 | | $ | 120 | | $ | 272 | | $ | 331 | | | | | | | | $ | (10) | | $ | 107 | | | $ | 363 | | $ | 272 | | | |
2628
Note 14 — Income Taxes
For the three and nine months ended May 31, 2023, the Company’s recognized effective tax rate was 25.1% and 23.6%, respectively. For the three and nine months ended May 31, 2022, the Company’s recognized effective tax rate was 19.7% and 23.3%, respectively. For the three and nine months ended May 31, 2021, the Company’s recognized effective tax rate was 19.5% and 23.1%, respectively.
The Company has applied the U.S. statutory Federal rate of 21%, enacted as part of the Tax Cuts and Jobs Act (the “Tax Act”) in December 2017, for both the third quarter and year-to-date fiscal periods ended May 31, 20222023 and 2021.2022.
In addition, the Company also recognizes an additional component of total Federal tax expense, the tax on Global Intangible Low-Taxed Income (“GILTI”) provision of the Tax Act, which became applicable to the Company in fiscal 2019. The Company elected to account for GILTI as a period cost, and therefore included GILTI expense in the effective tax rate calculation. This provision did not have a material effect on the effective tax rate for the third quarter and year-to-date fiscal periods ended May 31, 20222023 and 2021.2022. Additionally, the Company concluded that the Base Erosion and Anti AbuseAnti-Abuse Tax (“BEAT”) provision of the Tax Act, which also became applicable to the Company in fiscal 2019, had no effect on its effective tax rate for the third quarter and year-to-date fiscal periods ended May 31, 20222023 and 2021.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, included a technical correction to the Tax Act which will allow accelerated deductions for qualified improvement property. The Company has evaluated the impact of the CARES Act, and at present does not expect that the qualified improvement property correction or other provisions of the CARES Act will result in a material tax benefit in future periods. The CARES Act had no material effect on the effective tax rate for the third quarter and year-to-date fiscal periods ended May 31, 2022 and 2021.2022.
In July 2020, the United States Internal Revenue Service (“IRS”) released final regulations (TD 9901) that ease documentation standards and provide greater flexibility for taxpayers claiming the deduction for Foreign-Derived Intangible Income (“FDII”). During the third quarter and year-to-date fiscal periods ended May 31, 2022,2023, FDII had a favorable impact on the Company’s effective tax rate.
The Inflation Reduction Act ("IRA") was enacted into law on August 16, 2022. Included in the IRA was a provision to implement a 15% corporate alternative minimum tax on “adjusted financial statement income” for applicable corporations and a 1% excise tax on repurchases of stock. These provisions are effective for tax years beginning after December 31, 2022. We are in the process of evaluating the provisions of the IRA, but we do not currently believe the IRA will have a material impact on our reported results, cash flows or financial position.
0Note 15 — Operations Optimization Costs
ERP System Upgrade
During the first quarter of fiscal 2023, the Company began the process of upgrading our current Oracle Legacy ERP System to the Oracle Fusion Cloud Platform. This upgrade will position us with a more advanced system to support business expansion, access to upgrades in functionality and a more modern system for operations. Additionally, the upgrade will be a multi-year, phased-in approach designed to mitigate any disruptions to our business. The Company recognized $133 and $990 in operations optimization expense related to the ERP system upgrade in the third quarter and nine-month period of fiscal 2023, respectively.
Relocation of previous NuCera Corporate and R&D headquarters
During the third quarter of 2023 Chase moved out of the Woodlands, TX facility (previously NuCera Corporate and R&D headquarters) to a smaller R&D facility in Houston, TX. On the last day of the third fiscal quarter, the Company signed a sublease agreement for the Woodlands office and expensed $211 as a lease impairment related to this facility in the third quarter of the fiscal period. The project is now substantially complete, and any future costs related to the facility relocation are not anticipated to be significant to the condensed consolidated financial statements.
The Company wrote-off $120 of fixed assets primarily related to the R&D relocation of the Houston, TX facility in the third quarter and year-to-date period of fiscal 2023. The total third quarter and year-to-date expense related to the move of $331 is included in the Loss on impairment/write-off of long-term asset in the Condensed Consolidated Statement of Operations. The project is now substantially complete and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.
29
Relocation of Adhesives Systems Manufacturing to O'Hara Township, PA
During the third quarter of fiscal 2021, Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. Chase obtained the adhesives systems operations as part of its fiscal 2017 acquisition of the operations of Resin Designs. Operations optimization costs related to the consolidation of the Woburn, MA location of $82 and $516 were expensed in the third quarter and first nine-month period of fiscal 2023, respectively. Operations optimization costs related to the consolidation of the Woburn, MA location of $27 and $328 was expensed in the third quarter and year-to-date period of fiscal 2022.
On the last day of the second fiscal quarter, the Company signed a termination agreement with the landlord for the Woburn, MA facility and wrote off the right-of-use asset and liability of the Woburn, MA lease, expensing $314 in the second fiscal quarter of 2023. Additionally, the Company expensed $548 as a lease impairment related to the Woburn, MA facility in the first quarter of fiscal 2023. The total year-to-date expense related to the Woburn, MA facility of $862 is included in the Loss on impairment/write-off of long-term asset in the Condensed Consolidated Statement of Operations. The project is now substantially complete and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.
Relocation of Chase Corporate Headquarters
The Company substantially completed the relocation of its Corporate Headquarterscorporate headquarters to another location within Westwood, MA during the second quarter of the fiscal year ended August 31, 2022. The move, part of the Company’s ongoing consolidation and optimization initiative, capitalizes on the hybrid work model utilized by many of Chase’s corporate and administrative employees and is expected to provide future operational cost savings. The new facility also consolidates and houses research and development operations previously conducted at the previous Westwood, MA and Woburn, MA locations. Operations optimization expensescosts related to the Westwood move of $32 and $232 were expensed in the third quarter and fiscal year-to-date period of fiscal 2022, respectively. The Company does not anticipate any significant additional operations optimizationproject is complete and future costs related to the new Corporate Headquarters during the fourth quarter of themove are not anticipated in fiscal year.2023.
Relocation of Adhesives Systems Manufacturing to O'Hara Township, PA
During the third quarter of fiscal 2021, Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. This rationalization and consolidation initiative aligns with the announcement in the second quarter of fiscal 2021 of the Company’s plan to move its sealant systems production from Newark, CA to Hickory, NC, described in more detail below. Chase Corporation obtained both the adhesive and sealants systems as part of its fiscal 2017 acquisition of the operations of Resin Designs. The Company expensed $27 and $328 related to the consolidation of the Woburn, MA location during the third quarter and fiscal 2022 period, respectively, and expects to recognize additional expense during the fourth quarter of the fiscal year.
27
Relocation of Sealants Systems Manufacturing to Hickory, NC
During the second quarter of fiscal 2021, Chase began moving the sealant systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, from its Newark, CA location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. The sealant systems operations and Newark, CA location came to Chase Corporation as part of the fiscal 2017 acquisition of the operations of Resin Designs, and the Company’s lease there terminated in fiscal 2021. The Company recognized $977$0 and $147 of expense related to the move during the entire prior fiscal year ended August 31, 2021 and $0 and $147 of expense in the third quarter and year-to-date period, respectively, of fiscal 2022. This project is now substantially completedcomplete and any future costs related to this move are not anticipated to be significant to the condensed consolidated financial statements.anticipated.
2830
Note 16 — Long-Term Debt
On July 27, 2021 (the fourth quarter of fiscal 2021), the Company entered into the Second Amended and Restated Credit Agreement (the “New Credit“Credit Agreement”) by and among the Company and NEPTCO Incorporated (“NEPTCO”), each as borrowers, the guarantor subsidiaries party thereto, the financial institutions party thereto as Lenders, and Bank of America, N.A., as administrative agent, with participation from Wells Fargo Bank, N.A., PNC Bank, N.A. and JPMorgan Chase Bank, N.A. The New Credit Agreement was entered into to amend, restate and extend the Company’s preexisting Amended and Restated Credit Agreement (the “Prior Credit Agreement”), which had a maturity date of December 15, 2021, andis used to provide for additional liquidity to finance acquisitions, working capital and capital expenditures, and for other general corporate purposes. Under the NewThe Credit Agreement Chase obtained an increasedincludes a revolving credit loan (the “New Revolving“Revolving Facility”), with borrowing capabilities not to exceed $200,000 at any time, with the ability to request an increase in this amount by an additional $100,000 at the individual or collective option of any of the Lenders. Effective February 1, 2023, the Credit Agreement transitioned to a secured overnight financing rate (SOFR) in substitution for the London Interbank Offered Rate (LIBOR) and will commence at the next interest rate renewal period. The applicable interest rate for the New Revolving Facility and New Term Loan (defined below) is based on the effective London Interbank Offered Rate (LIBOR)SOFR base rate plus a rangeSOFR adjustment based on the term of the interest rate period plus a spread ranging from 1.00% to 1.75%, depending on the consolidated net leverage ratio of Chase and its subsidiaries. AtThe SOFR adjustment is based on interest rate periods of 1-month at .1%, 3-months at .15%, and 6-months at .25%. Prior to the transition to SOFR, the applicable interest rate for the Revolving Facility and Term Loan is based on the effective LIBOR plus a spread ranging from 1.00% to 1.75%, depending on the consolidated net leverage ratio of Chase and its subsidiaries. As of May 31, 2022, there was 0 outstanding principal balance, and2023, the Company had $130,000 in long-term debt related to the acquisition of NuCera Solutions that closed on September 1, 2022. The long-term debt has a weighted average interest rate of 6.6% as such, 0 applicable interest rate.of May 31, 2023.
The New Credit Agreement has a five-year term with interest payments due at the end of the applicable LIBOR or SOFR period (but in no event less frequently than the three-month anniversary of the commencement of such LIBOR or SOFR period) and principal payment due at the expiration of the agreement, July 27, 2026. The New Credit Agreement contains provisions that may replace LIBOR as the benchmark index under certain circumstances. In addition, the Company may elect a base rate option for all or a portion of the New Revolving Facility, in which case interest payments shall be due with respect to such portion of the New Revolving Facility on the last business day of each quarter. Subject to certain conditions set forth in the New Credit Agreement, the Company may elect to convert all or a portion of the outstanding New Revolving Facility into a new term loan twice during the term of the New Revolving Facility (each, a “New Term“Term Loan”, and collectively with the New Revolving Facility, the “New Credit“Credit Facility”), which New Term Loan shall be payable quarterly in equal installments sufficient to amortize the original principal amount of such Term Loan on a ten year amortization schedule.
The outstanding balance on the New Credit Facility is guaranteed by all of Chase’s direct and indirect domestic subsidiaries, which collectively had a carrying value of approximately $302,914$328,788 at May 31, 2022.2023. The New Credit Facility is subject to restrictive covenants under the New Credit Agreement, and financial covenants that require Chase and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a consolidated net leverage ratio of no greater than 3.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.50 to 1.00 (both defined in the New Credit Agreement). Chase Corporation was in compliance with the debt covenants as of May 31, 2022. The New Credit Agreement also placesrequires lender permission for acquisitions over a certain Lender-approval requirements as to the size, of permitted acquisitions which may be entered into by the Company and its subsidiaries, and allows for a temporary step-up in the allowedcompany to temporarily modify the consolidated leverage ratio forwhen an acquisition greater than $50,000 is consummated during an applicable measurement period. Due to the NuCera acquisition, the consolidated leverage ratio was not to exceed 3.75 to 1.00 as of the end of the four fiscal quarters ending after certain designated acquisitions.following the acquisition. Prepayment is allowed by the New Credit Agreement at any time during the term of the agreement, subject to customary notice requirements and the payment of customary LIBOR or SOFR breakage fees.
The Prior Chase Corporation was in compliance with the debt covenants under the Credit Agreement was an all-revolving credit facility with a borrowing capacityas of $150,000, which could be increased by an additional $50,000 at the request of the Company and the individual or collective option of any of the lenders, and with an interest rate based on the effective LIBOR plus an additional amount in the range of 1.00% to 1.75%, depending on our consolidated net leverage ratio or, at the Company’s option, at the bank’s base lending rate. It was substantially available at July 27, 2021, the time of its amendment and restatement.May 31, 2023.
29
Note 17 – Acquisitions
Acquisition of Emerging Technologies, Inc.NuCera Solutions
On February 5, 2021,September 1, 2022 (the first day of fiscal 2023), the Company acquired certain assetsall of Emerging Technologies, Inc.the capital stock of NuCera Solutions (“ETi”NuCera”), a superabsorbent. The NuCera acquisition extends our global reach in the production and development of highly differentiated specialty polymers solutions provider, located in Greensboro, NC. and polymerization technologies serving demanding applications, offering products critical to enabling end-product functionality, performance and reliability for new blue-chip customers and high-growth end markets such as personal care, polymer additives, coatings, diversified consumer products and masterbatches.
31
The business wasCompany acquired all of the capital stock of NuCera for a purchase price of $9,997, comprising $8,997 paid on February 5, 2021$250,000, net of debt, accrued income taxes, cash at closing, and an accrual of $1,000 to be paid out up to eighteen months after the purchase, subsequent to final working capital adjustments and excluding acquisition-related costs. As partresulting in a purchase price consideration of this transaction, Chase acquired substantially all working capital and fixed assets of the business and entered a multi-year lease at ETi’s existing location.$250,092. The Company expensed $128paid $249,594, net of acquisition-related costs during the three-month period ended February 28, 2021 associated with this acquisition.$498 of cash acquired. The purchase was funded withby utilizing $180,000 from the Company’s existing revolving credit facility and the remaining $70,000 from available cash on hand. ETi is a solutions provider and formulator of absorbent polymers for use in the packaging, recreational, consumer, and sanitation markets. The acquisition broadens the Company’s superabsorbent polymers product offerings and formulation capabilities while expanding its market reach. The Company finalized purchase accounting duringrecorded transaction costs of $29 in the first quarter of fiscal 2022, with no significant change to amounts initially recorded. Since the effective date of the acquisition, the financial results of ETi’s acquired operations have been included2023 and $4,000 in the Company’s financial statements withinfourth quarter of fiscal 2022 related to this acquisition which are excluded from the functional additives product line, contained withinpurchase price. Acquisition-related costs consist of legal and professional fees related to the Adhesives, Sealants and Additives operating segment. The ETi acquisition does not represent a significant business combination so pro forma financial information is not provided.NuCera acquisition.
The NuCera acquisition has been accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification Topic 805, Business Combinations, (“ASC 805”). The purchase price consideration has been allocated to the assets acquired and liabilities assumed of NuCera based upon preliminary estimate of their fair values as of the acquisition date. Fair values of the assets acquired and liabilities assumed are measured in accordance with ASC Topic 820, Fair Value Measurements, (“ASC 820”), using the discounted cash flows and other applicable valuation techniques. For certain assets and liabilities, those fair values are consistent with historical carrying values.
The following table summarizes the purchase consideration and the preliminary purchase price allocation to estimate fair values of the identifiable assets acquired and liabilities assumed as of the acquisition date (in thousands):
| | | |
Allocation of the Purchase Price | | | |
| | | |
Preliminary Purchase Price Allocation |
| Amount | |
Cash consideration | | $ | 250,092 |
Total fair value of consideration transferred | | | 250,092 |
| | | |
Assets acquired: | | | |
Cash and cash equivalents | | $ | 498 |
Accounts receivable | | | 10,392 |
Inventory | | | 16,063 |
Prepaid and other current assets | | | 4,849 |
Property, plant & equipment | | | 38,489 |
Operating lease right-of-use assets | | | 579 |
Goodwill | | | 81,349 |
Intangible assets | | | 148,021 |
Other assets | | | 211 |
Total assets acquired | | | 300,451 |
| | | |
Liabilities assumed: | | | |
Accounts payable | | $ | 4,731 |
Accrued expenses | | | 6,582 |
Income taxes payable | | | 167 |
Operating lease long-term liabilities | | | 474 |
Deferred income taxes | | | 38,306 |
Accrued income taxes | | | 99 |
Total liabilities assumed | | | 50,359 |
Net assets acquired | | $ | 250,092 |
The purchase price allocation is preliminary and subject to revision as acquisition-date fair value analyses are completed and if additional information about facts and circumstances that existed at the acquisition date become available. The purchase price consideration, as well as the estimated fair values of the assets acquired and liabilities assumed, will be finalized as practicable, but no later than one year from the closing of the NuCera acquisition.
The preliminary purchase price allocation resulted in goodwill of $81,349 of which $1,147 is deductible for income tax purposes. Goodwill consists of the excess of the purchase price over the fair value of the acquired assets and assumed liabilities representing the estimated economic value attributable to future operations.
32
At this time, except for the items noted below, we do not expect material changes to the value of the assets acquired or liabilities assumed in conjunction with the transaction. Specifically, deferred tax assets and liabilities are subject to change. As management receives additional information during the measurement period, these assets and liabilities may be adjusted. Under the acquisition method of accounting for business combinations, if we identify changes to acquired deferred tax asset valuation allowances or liabilities related to uncertain tax positions during the measurement period, and they are related to new information obtained about facts and circumstances that existed as of the acquisition date, those changes are considered a measurement-period adjustment, and we record the offset to goodwill. The Company will record all other changes to deferred tax asset valuation allowances and liabilities related to uncertain tax positions in current-period income tax expense. This accounting applies to all of our acquisitions, regardless of acquisition date.
The revenue and net tangibleloss for the results of operations for NuCera was $16,181 and ($2,080) in the third quarter of fiscal 2023. The revenue and net loss for the results of operations for NuCera was $53,879 and ($7,732) for the year-to-date period of fiscal 2023.
The pro forma summary below presents the results of operations as if the NuCera acquisition occurred on September 1, 2021. Proforma adjustments for the three months ended May 31, 2022 includes $3,064 of incremental amortization expense from acquired intangible assets, $2,308 of incremental interest expense, and the tax related impact. Proforma adjustments for the nine months ended May 31, 2022 includes $12,003 of incremental amortization expense from acquired resulted in goodwillintangible assets, $2,240 of $2,451inventory step-up, $6,833 of incremental interest expense, and the tax related impact. The pro forma summary uses estimates and assumptions based on information available at the time. Management believes the estimates and assumptions to be reasonable; however, actual results may have differed significantly from this pro forma financial information. The pro forma information does not reflect any cost savings, operating synergies or revenue enhancements that is largely attributable to the synergies and economies of scalemight have been achieved from combining the operations. The unaudited pro forma summary is provided for illustrative purposes only and does not purport to represent Chase’s actual consolidated results of operations technologies and research and development capabilities of ETi and Chase, particularlyhad the acquisition been completed as they pertain to the expansion of the Company's product and service offerings, the established workforce and marketing efforts. This goodwill is deductible for income tax purposes.date presented, nor should it be considered indicative of Chase’s future consolidated results of operations.
| | | | | | | | | | | | | | |
| | Three Months Ended May 31, | | Nine Months Ended May 31, | ||||||||||
| | 2023 |
| | 2022 | | 2023 |
| | 2022 | ||||
| | |
| | | | | |
| | | | ||
Revenue | | $ | 106,645 | | | $ | 113,573 | | $ | 303,818 | | | $ | 302,079 |
Net income | | | 12,092 | | | | 15,825 | | | 27,319 | | | | 31,340 |
Note 18 – Subsequent Event
AcquisitionLong-Term Debt Payment
On June 30, 2023, the Company made payments of ABchimie$10,000 on our revolving debt facility decreasing the balance of long-term debt to $120,000.
On September 1, 2020 (first day of fiscal 2021), the Company acquired all the capital stock of ABchimie for €18,654 (approximately $22,241 at the time of the transaction) net of cash acquired, subject to final working capital adjustments, excluding acquisition-related costs totaling $274 recognized in fiscal 2020 and with a performance-based earn out (measured over four years post-acquisition) potentially worth an additional €7,000 (approximately $8,330 at the time of the transaction). The Company had $2,692 accrued at February 28, 2022 within Other liabilities on the condensed consolidated balance sheet related to its estimate of the current fair value of the earn out. Following its initial recording at the acquisition date, changes in the performance-based earn out accrual have been recorded within (Gain) loss on contingent consideration in the condensed consolidated statement of operations (including a $474 gain in the third quarter and $199 year-to-date net gain adjustment in fiscal 2022).
ABchimie is a Corbelin, France headquartered solutions provider for the cleaning and protection of electronic assemblies, with further formulation, production, and research and development capabilities. The transaction was funded with available cash on hand. The financial results of the business are included in the Company's financial statements within the Adhesives, Sealants and Additives operating segment in the electronic and industrial coatings product line. The Company finalized purchase accounting during the fourth quarter of fiscal 2021, with no significant change to amounts initially recorded.
The excess of the purchase price over the net tangible and intangible assets acquired resulted in goodwill of $13,055 that is largely attributable to the synergies and economies of scale from combining the operations, technologies and research and development capabilities of ABchimie and Chase, particularly as they pertain to the expansion of the Company's product and service offerings, the established workforce and marketing efforts. A portion of this goodwill is deductible in the U.S. for calculation of GILTI period costs but is nondeductible for French income tax purposes.
3033
Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion provides an analysis of the Company’s financial condition and results of operations.operations for the third quarter and nine-month period ending May 31, 2023. It should be read in conjunction with the Condensed Consolidated Financial Statements. NotesStatements and notes thereto are included in Item 1 of Part I of this Quarterly Report on Form 10-Q and with the Company’s Annual Report on Form 10-K filed for the fiscal year ended August 31, 2021.2022.
Executive Overview
GeneralResults of Operations
The Company’s revenue grew in the third fiscal quarter and nine months ended May 31, 2022,2023, with all three of its reportablethe Adhesives, Sealants and Additives and Industrial Tapes operating segments surpassing salesrevenue achieved in the prior comparable quarter. The increase for the third quarter of the fiscal period was primarily attributed to inorganic growth from our NuCera Solutions (“NuCera”) business acquired in the first month of fiscal 2023 and our electronic and industrial coatings product line (included within our Adhesives, Sealants and Additives operating segment) coupled with revenue generated from our specialty products and pulling and detection product lines (included within our Industrial Tapes operating segment). Tempering the overall increase in third quarter revenue was decreased demand seen in our Corrosion Protection and Waterproofing operating segment.
The Company’s gross margin as a percentage of revenue was 37.7% and 36.5% in the third quarter and nine-month period of fiscal 2023, compared to 38.6% and 37.4% in the third quarter and nine-month period of fiscal 2022, respectively. Despite the Company’s sales growth in both the third quarter and year-to-date period, the Company continues to have less favorable gross margin compared to the comparable prior year period. The decrease in gross margin percentage in the comparable third quarter and nine-month period is primarily attributed to lower gross margin from our NuCera business. Additionally, the Company’s gross margin for the third quarter and year-to-date period was negatively impacted by customer destocking caused by customer inventory reduction initiatives seen in the third quarter and year-to-date period of fiscal 2023.
After being negatively impacted by inflationary pressures in fiscal 2022, the gross margin for our organic business has stabilized due to measures implemented in fiscal 2022, including sales price increases fully realized in the first half of fiscal 2023 and the Company’s supply chain strategy to actively explore secondary sourcing initiatives to locate alternative suppliers for our critical raw materials. Inflationary pressures did not have a significant impact on our profitability in the third quarter and year-to-date fiscal periods. Despite the ongoing challenges of the globalperiod.
The Company’s operating environment detailed below, the Companyexpenses increased its gross margin to 38.6% in the third quarter resultingand nine-month period of fiscal 2023 over the comparable prior periods. The increase in a 37.4% gross margin foroperating expenses is attributed to incremental monthly depreciation and amortization related to our NuCera business, lease impairment and write-off of long-term assets, and first quarter purchase accounting adjustments (including backlog fully amortized during the first fiscal quarter of the fiscal period), all of which negatively impacted operating income over the third quarter and year-to-date fiscal period.
DespiteBalance Sheet and Cash Flow
Chase Corporation’s balance sheet remained healthy as of May 31, 2023, with cash on hand of $43,071,000, and a current ratio of 5.2. The Company’s cash position remained steady including cash flow from operations and debt paydown. The Company’s disciplined inventory reduction approach in the Company’s healthy sales growth in both the current quarter and year-to-date period, and an increase in third quarter gross margin comparedhas continued to the [second quarter][first half of fiscal 2022],allow the Company continues to have a less favorable gross margin percentage inmake subsequent payments on our long-term debt and improve cash flow. Furthermore, during the currentsecond fiscal quarter and year-to-date period compared to the prior year periods. Lower operating costs seen in the current quarter resulted in higher operating income over the comparable quarter. Higher operating costs seen in the year-to-date current period resulted in decreased operating income over the comparable year-to-date period. Chase’s relative gross margin in the quarter and year-to-date period continue to be negatively impacted by both: a.) increased input costs caused by continued global raw material inflationary pressures, increased logistics costs and a more competitive labor market; and b.) a less favorable sales mix, with sales increases in its lower margin Industrial Tapes segment outpacing revenue gains seen in its higher margin Adhesives, Sealants and Additives, and Corrosion Protection and Waterproofing segments. Further, the Adhesives, Sealants and Additives segment also experienced a less favorable sales mix within the segment itself due to historically less favorable margin products constituting a comparatively larger partChase Corporation paid out an annual cash dividend of total segment sales in the quarterly and year-to-date periods.$9,500,000 on December 9, 2022.
The Company continueshad a $130,000,000 outstanding balance on its $200,000,000 revolving credit facility as of May 31, 2023, related to work with our customers and suppliers in an effort to counteract margin compression. However, given the delay experienced due to notification period requirements with certain customers and the continuation of upward inflationary pressures on input costs, the current period and year-to-date results reflect a lag in the realizationfunding of the full benefits of these efforts.NuCera acquisition as noted above. The revolving credit facility, which was amended and restated in July 2021 to increase its capacity from $150,000,000 to $200,000,000, allows for the Company to pay down debt with excess cash, while retaining access to immediate liquidity to fund future accretive activities, including mergers
3134
and acquisitions, as they are identified. The facility also gives Chase the ability to request an increase in this amount by an additional $100,000,000 ($300,000,000 in total borrowing capacity) at the individual or collective option of any of the lenders. The facility matures in July 2026.
Results of Operations
Revenue
Total revenue increased $18,026,000, or 20% to $106,645,000 for the quarter ended May 31, 2023, compared to $88,619,000 in the same quarter of the prior year. Out of the $18,026,000 increase in quarterly revenue, 90% relates to inorganic revenue from our NuCera business and the remaining increase in revenue is primarily attributed to sales price increases fully realized in fiscal 2023. Total revenue increased $66,236,000, or 28% to $303,818,000, in the fiscal year-to-date period compared to $237,582,000 in the comparable period in fiscal 2022. Out of the $66,236,000 increase in fiscal year-to-date revenue, 81% relates to inorganic revenue from our NuCera business. The remaining increase in revenue is primarily attributed to sales price increases fully realized in fiscal 2023.
Revenue by Segment
Chase Corporation has three reportable operating segments as summarized below:
| | | | |
Segment |
| Product Lines |
| Manufacturing Focus and Products |
Adhesives, Sealants and Additives | | Electronic and Industrial Coatings | | Protective coatings, including moisture protective coatings and cleaning chemistries, and customized sealant and adhesive systems for electronics; polyurethane dispersions, polymeric microspheres and superabsorbent polymers; highly differentiated specialty waxes and polymers. |
Industrial Tapes | | Cable Materials Specialty Products Pulling and Detection Electronic Materials | | Protective tape and coating products and services, including insulating and conducting materials for wire and cable manufacturers; laminated durable papers, packaging and industrial laminate products and custom manufacturing services; pulling and detection tapes used in the installation, measurement and location of fiber optic cables and water and natural gas lines; cover tapes essential to delivering semiconductor components via tape-and-reel packaging. |
Corrosion Protection and Waterproofing | | Coating and Lining Systems Pipeline Coatings Building Envelope Bridge and Highway | | Protective coatings and tape products, including coating and lining systems for use in liquid storage and containment applications; protective coatings for pipeline and general construction applications; adhesives and sealants used in architectural and building envelope waterproofing applications; high-performance polymeric asphalt additives and expansion and control joint systems for use in the transportation and architectural markets. |
Revenue for our Adhesives, Sealants and Additives segment increased for the third quarter and year-to-date periods against the comparable prior year periods with increased demand for our North American-focused functional additives product line, including year-to-date inorganic growth from our Emerging Technologies, Inc. (“ETi”) business acquired in the last month of the second quarter of fiscal 2021. Partially offsetting this increase in revenue was a quarter to quarter and year-to-date reduction in sales volume from our worldwide-focused electronic and industrial coatings product line due to reduced demand acutely seen with sales within the automotive industry for the third quarter and year-to-date fiscal periods.
Revenue for our Industrial Tapes segment surpassed the COVID-19 impacted third quarter and year-to-date prior year sales with continued increased demand for our North American-focused cable materials, and pulling and detection product lines. Tempering the increase in third quarter revenue was a decrease in third quarter sales from the specialty products product line due to raw material supply constraints. However, the specialty products product line continues to experience a year-to-date increase in sales over the prior year-to-date comparable period.
Revenue for our Corrosion Protection and Waterproofing segment surpassed the prior year quarter and year-to-date periods with increased demand from our pipeline coatings line benefiting in the current quarter, and our building envelope lines benefitting both in the current quarter and year-to-date periods. Partially offsetting these increases in revenue were current quarter and year-to-date reductions in net sales volume from our bridge and highway product lines. The coatings and lining systems product line also experienced reduction in net sales volume in the current quarter compared to the prior year quarter and continues to experience an increase in year-to-date sales compared to the prior comparable period.
3235
Balance Sheet and Cash Flow
Chase Corporation’s balance sheet remained strong as of May 31, 2022, with cash on hand of $124,683,000, and a current ratio of 8.1. The Company’s cash position remained healthy, as did cash flow from operations. Chase continued its strategic inventory build during the third quarter, undertaken to help ensure its ability to satisfy our customers’ demands and to address its elevated backlog caused in part by supply chain challenges. In addition, during the second fiscal quarter Chase Corporation paid out its largest ever annual cash dividend of $9,460,000 on December 9, 2021.
The Company held no outstanding balance on its $200,000,000 revolving credit facility as of May 31, 2022. The revolving credit facility, which was amended and restated in July 2021 (fourth quarter of fiscal 2021) to increase its capacity from $150,000,000 to $200,000,000, allows for the Company to pay down debt with excess cash, while retaining access to immediate liquidity to fund future accretive activities, including mergers and acquisitions, as they are identified. The new facility also gives Chase the ability to request an increase in this amount by an additional $100,000,000 ($300,000,000 in total borrowing capacity) at the individual or collective option of any of the lenders. The facility matures in July 2026.
33
Results of Operations
Revenue and Incomeincome before Income Taxesincome taxes by Segment were assegment we are follows (dollars in thousands):
| | | | | | | | | | | | | | | | | | | | | | |
| | |
| % of |
| |
| % of |
| | |
| % of |
| |
| % of |
| ||||
| | Three Months Ended | | Total | | Three Months Ended | | Total | | | Nine Months Ended | | Total | | Nine Months Ended | | Total |
| ||||
|
| May 31, 2022 |
| Revenue |
| May 31, 2021 |
| Revenue |
| | May 31, 2022 |
| Revenue |
| May 31, 2021 |
| Revenue | | ||||
| | | | | | | | | | | | | | | | | | | | | | |
Revenue | | | | | | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 36,771 | | 41 | % | $ | 33,861 | | 43 | % | | $ | 99,600 | | 42 | % | $ | 95,507 | | 44 | % |
Industrial Tapes | | | 38,329 | | 43 | % | | 32,249 | | 41 | % | | | 104,420 | | 44 | % | | 87,085 | | 40 | % |
Corrosion Protection and Waterproofing | |
| 13,519 | | 15 | % |
| 13,483 | | 17 | % | |
| 33,562 | | 14 | % |
| 32,624 | | 15 | % |
Total | | $ | 88,619 | | | | $ | 79,593 | | | | | $ | 237,582 | | | | $ | 215,216 | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | % of | |
| | | % of | | |
| | % of | | | | | % of | | ||
| | Three Months Ended | | Segment | | Three Months Ended | | Segment | | | Nine Months Ended | | Segment | | Nine Months Ended | | Segment | | ||||
| | May 31, 2022 | | Revenue | | May 31, 2021 | | Revenue | | | May 31, 2022 | | Revenue | | May 31, 2021 | | Revenue | | ||||
Income before income taxes | | | | | | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 12,320 | (a) | 34 | % | $ | 10,982 | (c) | 32 | % | | $ | 27,719 | (a) | 28 | % | $ | 31,098 | (c) | 33 | % |
Industrial Tapes | | | 10,985 | | 29 | % | | 10,945 | | 34 | % | | | 30,525 | | 29 | % | | 27,273 | | 31 | % |
Corrosion Protection and Waterproofing | |
| 5,353 | | 40 | % |
| 5,098 | | 38 | % | |
| 12,683 | | 38 | % |
| 11,599 | | 36 | % |
Total for reportable segments | |
| 28,658 | | 32 | % |
| 27,025 | | 34 | % | |
| 70,927 | | 30 | % |
| 69,970 | | 33 | % |
Corporate and Common Costs | |
| (9,310) | (b) | | |
| (9,282) | (c) | | | |
| (26,095) | (b) | | |
| (25,385) | (c) | | |
Total | | $ | 19,348 | | 22 | % | $ | 17,743 | | 22 | % | | $ | 44,832 | | 19 | % | $ | 44,585 | | 21 | % |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| | Three |
| |
| Three |
| |
| | Nine |
| |
| Nine |
| |
| ||||
| | Months Ended | | % of | | Months Ended | | % of | | | Months Ended | | % of | | Months Ended | | % of |
| ||||
| | May 31, | | Total | | May 31, | | Total | | | May 31, | | Total | | May 31, | | Total | | ||||
|
| 2023 |
| Revenue |
| 2022 |
| Revenue |
| | 2023 |
| Revenue |
| 2022 |
| Revenue | | ||||
| | | | | | | | | | | | | | | | | | | | | | |
Revenue | | | | | | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 55,083 | | 52 | % | $ | 36,771 | | 41 | % | | $ | 159,370 | | 52 | % | $ | 99,600 | | 42 | % |
Industrial Tapes | | | 40,927 | | 38 | % | | 38,329 | | 43 | % | | | 116,987 | | 39 | % | | 104,420 | | 44 | % |
Corrosion Protection and Waterproofing | |
| 10,635 | | 10 | % |
| 13,519 | | 15 | % | |
| 27,461 | | 9 | % |
| 33,562 | | 14 | % |
Total | | $ | 106,645 | | | | $ | 88,619 | | | | | $ | 303,818 | | | | $ | 237,582 | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| | Three | | | | Three | | | | | Nine | | | | Nine | | | | ||||
| | Months Ended | | % of | | Months Ended | | % of | | | Months Ended | | % of | | Months Ended | | % of | | ||||
| | May 31, | | Segment | | May 31, | | Segment | | | May 31, | | Segment | | May 31, | | Segment | | ||||
| | 2023 | | Revenue | | 2022 | | Revenue | | | 2023 | | Revenue | | 2022 | | Revenue | | ||||
Income before income taxes | | | | | | | | | | | | | | | | | | | | | | |
Adhesives, Sealants and Additives | | $ | 9,523 | (a) | 17 | % | $ | 12,320 | (d) | 34 | % | | $ | 19,268 | (a), (b) | 12 | % | $ | 27,719 | (d) | 28 | % |
Industrial Tapes | | | 12,710 | | 31 | % | | 10,985 | | 29 | % | | | 36,915 | | 32 | % | | 30,525 | | 29 | % |
Corrosion Protection and Waterproofing | |
| 3,689 | | 35 | % |
| 5,353 | | 40 | % | |
| 8,703 | | 32 | % |
| 12,683 | | 38 | % |
Total for reportable segments | |
| 25,922 | | 24 | % |
| 28,658 | | 32 | % | |
| 64,886 | | 21 | % |
| 70,927 | | 30 | % |
Corporate and Common Costs | |
| (9,774) | (c) | | |
| (9,310) | (e) | | | |
| (29,146) | (c) | | |
| (26,095) | (e) | | |
Total | | $ | 16,148 | | 15 | % | $ | 19,348 | | 22 | % | | $ | 35,740 | | 12 | % | $ | 44,832 | | 19 | % |
| | | | | | | | | | | | | | | | | | | | | | |
Note: Some percentage of total revenue amounts may not sum to 100% due to rounding.
(a) | Includes a $129 loss in the third quarter and a $563 year-to-date loss on the upward adjustment of the performance-based earn out contingent consideration associated with the September 2020 acquisition of ABchimie, $82 and $516 in operations optimization costs related to the move from Woburn, MA to O’Hara Township, PA in the third quarter and year-to-date period, respectively, $0 and $862 loss on impairment/write-off of long-term assets related to the Woburn, MA facility in the third quarter and year-to-date period, respectively, and $331 and $331 loss on impairment/write-off of long-term assets related to the relocation of the Woodlands, TX facility to the new NuCera-related R&D facility in Houston, TX in the third quarter and year-to-date period, respectively |
(b) | Includes $2,200 of purchase accounting inventory adjustment related to the Company’s NuCera business and $2,820 of backlog amortization fully amortized related to the Company’s NuCera business both incurred during the first quarter of the fiscal year |
(c) | Includes $133 and $990 of operations optimization costs in the third quarter and year-to-date period, respectively, related to the Company’s ERP upgrade |
(d) | For 2022, includes a $474 gain in the third quarter and a $199 year-to-date gain on the adjustment of the performance-based earn-out contingent consideration associated with the September 2020 acquisition of ABchimie and $27 and $328 in operation optimization costs in the third quarter and year-to-date period |
3436
Total Revenue
Total revenue increased $9,026,000, or 11% to $88,619,000 for the quarter ended May 31, 2022, compared to $79,593,000 in the same quarter of the prior year. Total revenue increased $22,366,000, or 10% to $237,582,000 in the fiscal year-to-date period compared to $215,216,000 in the same period in fiscal 2021.
Revenue in the Company’sour Adhesives, Sealants and Additives segment increased $2,910,000,in the third quarter and year-to-date period against the comparable prior year periods. The segment revenue increased $18,312,000, or 9%50% and $4,093,000,$59,770,000, or 4%60% in the current quarter and year-to-date period, respectively. Positively impacting sales for bothThe third quarter and year-to-date revenue increase was predominately due to the currentinorganic growth from our NuCera business acquired on the first day of fiscal 2023, totaling $16,181,000 and $53,879,000 in the third quarter and year-to-date period, were demand-drivenrespectively. The remaining revenue increase for the third fiscal quarter and first nine-month period of the fiscal year was primarily attributed to sales price increases realized over the comparable prior periods and increased demand for our world-wide focused electronic and industrial coatings product line, totaling $5,700,000 and $9,069,000 in the third quarter and nine-month period of $3,416,000fiscal 2023. Partially offsetting this increase in revenue in the third fiscal quarter and $7,804,000, respectively, byyear-to-date period was reduction in revenue in our North American-focusedorganic functional additives product line which includes year-to-date inorganic growth attributabledue to decreased customer demand in North America over the ETi business acquiredcomparable prior fiscal quarter, totaling $3,569,000 and $3,178,000 in the last month ofcurrent fiscal quarter and year-to-date period, respectively.
Revenue for our Industrial Tapes segment increased in the secondthird quarter of fiscal 2021. Negatively impactingand year-to-date period over the segment’s sales was volume-driven decreasescomparable prior year periods. The segment revenue increased $2,598,000, or 7% and $12,567,000, or 12% in the current quarter and year-to-date period, for its worldwide-focused electronic and industrial coatings line totaling $506,000 and $3,711,000, respectively, with logistics and raw material supply constraints affecting demand in automotive verticals.
Compared torespectively. Sales price increases realized over the prior year periods and increased demand for our North American-focused specialty products and pulling and detection product line, which increased by $4,056,000 and $6,638,000, respectively, positively impacted revenue for the third quarter and year-to-date period. In addition, our North American-focused cable materials product line continues to experience a year-to-date increase in revenue over the comparable year-to-date period, totaling $7,754,000. Partially offsetting the increase in third quarter revenue was a decrease in demand in our cable materials product line over the Company’s Industrial Tapescomparable prior year quarter due to previous year increased demand attributed to customer inventory increase initiatives in reaction to supply chain shortages, totaling a decrease of $467,000. Also tempering the overall increase in revenue for the segment increased $6,080,000, or 19%was a third quarter and $17,335,000, or 20%, respectively. Positively impactingyear-to-date reduction in sales for bothvolume from our Asia-focused electronic materials product line, totaling $991,000 and $1,825,000 in the current quarter and year-to-date period, were sales price and volume-driven increases of $6,351,000 and $17,063,000, respectively due to its wire and cable, pulling and detection, and electronic materials product lines over the COVID-19 impacted prior year periods. Negatively impacting the sales increase for the quarter was its specialty product line totaling a sales decrease of $271,000 due to raw material supply constraints. However, the specialty products line continues to experience a year-to-date sales increase of $272,000 over the comparable year-to-date period.respectively.
Revenue in the Company’s Corrosion Protection and Waterproofing segment increased $36,000, or less than 1% fordecreased in the currentthird quarter and increased $938,000, or 3% in the year-to-date period respectively. Positively impactingover the comparable prior year periods. The segment sales for the current quarter was the demand-driven sales pricerevenue decreased $2,884,000, or 21% and volume increases in its pipeline coatings and building envelope product lines totaling $728,000 and $299,000, respectively, due to continued recovery in our oil and gas pipeline business attributable to our pipeline coatings product line and increased construction demand attributable to our building envelope product lines. Negatively impacting the segment’s sales was a decrease in revenue from its bridge and highway product lines totaling $126,000 and $131,000$6,101,000, or 18% in the current quarter and year-to-date period, respectively,respectively. Negatively impacting sales for the segment was a reduction in sales volume for our building envelope product line over the comparable prior year periods attributed to customer destocking, totaling $600,000 and $3,187,000 in the third quarter and year-to-date periods, respectively. Also, negatively impacting sales for the segment was a reduction in sales volume for our coating and linings product line in the third quarter and year-to-date period primarily attributed to delayed customer projects due to the extended rainy season in the west coast of North America. This was coupled with increased prior year demand due to customer inventory increase initiatives in reaction to supply chain shortages, totaling $550,000 and $1,522,000 in the current quarter and year-to-date period. Additionally, negatively impacting segment sales was our pipeline coatings product line attributed to delayed projects in the Middle East market over the prior comparable quarter and year-to-date period coupled with customer destocking initiatives in North American oil and gas markets, totaling $1,631,000 and $1,550,000 in the current quarter and year-to-date period, respectively. Furthermore, negatively impacting segment sales was decreased demand in our bridge and highway product line for the third quarter due to delayed project demand. Negatively impacting the quarter was the coatingsbridge and lining product lineshighway projects in North America, totaling a loss of $566,000 due to the strong prior year quarter activity after the winter weather events which impacted the Houston, TX manufacturing facility$103,000. However, our bridge and surrounding regions. However, the coatings and lininghighway product line experiencedis experiencing an increase of $770,000 in revenue for the fiscal year-to-date period, compared to the prior year comparable period.totaling $158,000.
35
Cost of Products and Services Sold
Cost of products and servicesservice sold increased $8,126,000,$11,999,000, or 18%22% to $54,438,000$66,437,000 for the quarter ended May 31, 2022,2023, compared to $46,312,000$54,438,000 in the prior year quarter. CostsCost of products and services sold increased $21,798,000,$44,428,000, or 17%30% to $148,630,000$193,058,000 in the first nine months of fiscal 2022,2023, compared to $126,832,000$148,630,000 in the comparative year-to-date period.
37
The following table summarizes the cost of products and services sold as a percentage of revenue for each of Chase Corporation’s reportable operating segments:
| | | | | | | | | | | | | |
| | | Three Months Ended May 31, | Nine Months Ended May 31, | | | | ||||||
Cost of products and services sold | |
| 2022 |
| 2021 |
| | 2022 |
| 2021 | | |
|
Adhesives, Sealants and Additives | | | 57 | % | 56 | % | | 60 | % | 55 | % | | |
Industrial Tapes | | | 67 | | 62 | | | 67 | | 64 | | | |
Corrosion Protection and Waterproofing | | | 56 | | 55 | | | 56 | | 57 | | | |
Total Company | | | 61 | % | 58 | % | | 63 | % | 59 | % | | |
| | | | | | | | | | | | | |
| | | Three Months Ended May 31, | Nine Months Ended May 31, | | | | ||||||
Cost of products and services sold | |
| 2023 |
| 2022 |
| | 2023 |
| 2022 | | |
|
Adhesives, Sealants and Additives | | | 61 | % | 57 | % | | 63 | % | 60 | % | | |
Industrial Tapes | | | 65 | | 67 | | | 65 | | 67 | | | |
Corrosion Protection and Waterproofing | | | 58 | | 56 | | | 61 | | 56 | | | |
Total Company | | | 62 | % | 61 | % | | 64 | % | 63 | % | | |
Cost of products and services sold in the Adhesives, Sealants and Additives segment was $21,073,000$33,620,000 and $59,828,000$100,621,000 in the current quarter and year-to-date period compared to $18,850,000$21,073,000 and $52,461,000$59,828,000 in the comparable periods in the prior year. Cost of products and services sold in the Industrial Tapes segment was $25,836,000$26,609,000 and $69,845,000$75,805,000 in the current quarter and year-to-date period compared to $20,043,000$25,836,000 and $55,853,000$69,845,000 in the comparable periods in the prior year. Cost of products and services sold in the Corrosion Protection and Waterproofing segment was $7,529,000$6,208,000 and $18,957,000$16,632,000 in the current quarter and year-to-date period compared to $7,419,000$7,529,000 and $18,518,000$18,957,000 in the comparable periods in the prior year.year period.
As a percentage of revenue, cost of products and services increased for both the Adhesives, Sealants and Additives and Industrial Tapes segment in the current quarter and year-to-date period. As a percentage of revenue, costs of products and services sold for the Corrosion Protection and Waterproofing segment increasedas compared to the prior year third quarter and year-to-date periods. The decrease in relative gross margin for our Adhesives, Sealants and Additives segment in the currentthird quarter and decreased in the year-to-date period.period was impacted by lower historical gross margin from our NuCera business. The decrease in the relative gross margin for the Adhesives, SealantsCorrosion Protection and AdditivesWaterproofing segment for the third quarter and nine-month period was primarily attributed to decreased production volume affecting overheard variances. As a percentage of revenue, cost of products and services sold decreased for the Industrial Tapes segment for the currentthird quarter and year-to-date period wasperiods due to continued global raw material inflationary pressures, increased logistics and freight costs and a more competitive labor market. Additionally,sales price increases realized during the Company’s overall relative margin was affected by a less favorable sales mix with sales increases in our lower margin Industrial Tapes segment outpacing revenue gains seen in our Adhesive, Sealants and Additives and Corrosion Protection and Waterproofing segments. The Adhesives, Sealants and Additives segment also experienced a less favorable sales mix within the segment itself, with historically less favorable margin products constituting a comparatively larger part of total segment sales. The Company has implemented and continues to implement customer price adjustments and continues to work with our customers and suppliers in an effort to counteract margin compression but with a lag reflected in current quarter and year-to-date period results.year 2023.
With the composition of the Company’s finished goods and the markets it serves, the costs of certain commodities (including petroleum-based solvents, films, yarns, polymers and nonwovens, aluminum and copper foils, specialty papers, and various resins, adhesives and inks) directly and indirectly affect both the purchase price of the raw materials and the market demand for its product offerings. In an effort to preserve margins, the Company diligently monitors raw materials and commodities pricing across all its product lines.
Selling, General and Administrative Expenses
Selling, general and administrative expenses decreased $162,000,increased $5,382,000, or 1%39% to $13,807,000$19,189,000 for the quarter ended May 31, 20222023 compared to $13,969,000$13,807,000 in the prior year quarter. Selling, general and administrative expenses increased $1,747,000,$18,925,000, or 5%47% to $40,307,000$59,232,000 in the fiscal year-to-date period compared to $38,560,000$40,307,000 in the same period in fiscal 2021.2022. The year-to-datequarter-to-quarter increase in activityexpense is attributedpredominately due to total increased sellingthe inclusion of expenses from our NuCera business (including additional amortization expected to recur in future periods and sales activity costs overbacklog intangible that was fully amortized during the comparable prior year-to-date period.first fiscal quarter), which was acquired on the first day of fiscal 2023. As a percentage of revenue, selling, general and administrative expenses represented 18% and 19% for the third quarter and year-to-date period, respectively, ended May 31, 2023 and 16% and 17% for the three-prior third quarter and nine-month periods of the fiscal year,year-to-date period, respectively, and 18% in the comparable three- and nine-month periods of the prior year.ended May 31, 2022.
36
Research and Product Development Costs
Research and product development costs increased $229,000,$341,000, or 24% percent29% to $1,186,000$1,527,000 during the third quarter of fiscal 2022,2023, compared to $957,000$1,186,000 in fiscal 2021.2022. Research and product development costs increased $240,000,$1,207,000, or 8% percent37% to $3,274,000$4,481,000 during the first nine months of fiscal 2022,2023, compared to $3,034,000$3,274,000 in the same period of fiscal 2021. Research2022. The increase in research and product development costs increased fromin the current quarter and year-to-date fiscal 2021period is primarily related to 2022 asour NuCera business, which was acquired in the Company continued focused development work on strategic product lines.first month of fiscal 2023.
38
Operations Optimization Costs
ERP System Upgrade
During the first quarter of fiscal 2023, the Company began the process of upgrading our current Oracle Legacy ERP System to the Oracle Fusion Cloud Platform. This upgrade will position us with a more advanced system to support business expansion, access to upgrades in functionality and a more modern system for operations. Additionally, the upgrade will be a multi-year, phased-in approach designed to mitigate any disruptions to our business. The Company substantially completed the relocation of its Corporate Headquarters to another location within Westwood, MA during the second quarter of the fiscal year. The move, part of the Company’s ongoing consolidationrecognized $133,000 and $990,000 in operations optimization initiative, capitalizes on the hybrid work model utilized by many of Chase’s corporate and administrative employees and is expected to provide future operational cost savings. The facility will consolidate and house research and development operations previously conducted at the previous Westwood, MA and Woburn, MA locations. Operations optimization costsexpense related to the Westwood move of $32,000 and $232,000 were expensedERP system upgrade in the third quarter and year-to-datenine-month period of fiscal period,2023, respectively. The Company does not anticipate any significant additional operations optimization costs related
Relocation of Adhesives Systems Manufacturing to the new Corporate Headquarters during the fourth quarter of the fiscal year.O'Hara Township, PA
During the third quarter of fiscal 2021, Chase announced to the employees at its Woburn, MA location that its adhesives systems operations, part of the Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line, would be consolidating into the Company’s existing O'Hara Township, PA location. This rationalization and consolidation initiative aligns with the announcement in the second quarter of fiscal 2021 of the Company’s plan to move its sealant systems production from Newark, CA to Hickory, NC, described in more detail below. Chase Corporation obtained both the adhesive and sealantsadhesives systems operations as part of its fiscal 2017 acquisition of the operations of Resin Designs. The Company expensed $27,000recognized $82,000 and $328,000,$516,000 in operations optimization expense related to the consolidation of the Woburn, MA location during the third quarter and year-to-datefirst nine-month period of fiscal year, respectively,2023, respectively. The Company recognized $27,000 and expects$328,000 in operations optimization expense related to recognize additional expensethe consolidation of the Woburn location during the fourththird quarter and first nine-month period of fiscal 2022, respectively.
Loss on Impairment/write-off of long-term assets
As part of the Company’s ongoing consolidation and optimization initiative, during the third quarter of 2023 Chase moved out of the Woodlands, TX facility (previously NuCera Corporate and R&D headquarters) to a smaller R&D facility in Houston, TX. On the last day of the third fiscal quarter, the Company signed a sublease agreement for the Woodlands office and expensed $211,000 as a lease impairment related to this facility in the third quarter of the fiscal year.period. The project is now substantially complete, and any future costs related to the facility relocation are not anticipated to be significant to the condensed consolidated financial statements.
DuringThe Company wrote off $120,000 of fixed assets primarily related to the R&D relocation of the Houston, TX facility in the third quarter and year-to-date period of fiscal 2023.
On the last day of the second fiscal quarter, the Company signed a termination agreement with the landlord for the Woburn, MA facility and wrote off the right-of-use asset and liability of the Woburn, MA lease, expensing $314,000 in the second fiscal quarter of fiscal 2021, Chase began moving2023. Additionally, the sealant systems operations,Company expensed $548,000 as a lease impairment related to the Woburn, MA facility relocation, as part of the relocation of the Company’s Adhesives, Sealants and Additives segment’s electronic and industrial coatings product line from its Newark, CA location to its Hickory, NC facility. This is in line with the Company’s ongoing initiative to consolidate its manufacturing plants and streamline its existing processes. The sealant systems operations and Newark, CAO’Hara Township, PA location came to Chase Corporation as part of the fiscal 2017 acquisition of the operations of Resin Designs, and the Company’s lease there terminated in fiscal 2021. The Company recognized $977,000 in expense related to the move during the entire prior fiscal year ended August 31, 2021, of which $98,000 was recognized in the first half of the year. The Company recognized $147,000 in expense during both the first halfquarter of fiscal 2022. This2023. The project is now substantially completedcomplete and any future costs related to this move are not anticipated to be significant.significant to the condensed consolidated financial statements.
37
TableThe Company’s total combined year-to-date expense of Contents$1,193,000 is included in the Loss on impairment/write-off of long-term assets in the Condensed Consolidated Statement of Operations.
Loss (Gain) loss on Contingent Consideration
As a componentpart of the September 1, 2020 (fiscal 2021) acquisition of ABchimie, the Company incurred a performance-based earn out liability potentially worth an additional €7,000,000 (approximately $8,330,000 at the time of the transaction) in consideration. Following its initial recording of an accrual for $928,000 at the acquisition date, $1,664,000 and $432,000 in expenseexpenses related to adjustments to the performance-based earn out accrual waswere recorded during the fiscal yearyears ended August 31, 2021 (with $733,000and 2022, respectively. The Company recognized an expense of expense recognized$129,000 and $563,000 in the secondthird quarter and first halfyear-to-date period of fiscal 2021). The Company2023, respectively, and recognized a gain of $474,000 and gain of $199,000 in the prior period third quarter and a net $199,000 gain over the fiscal year-to-date period, respectively, related to the performance-based contingent consideration.
39
Interest Expense
InterestThe Company recognized interest expense increased $21,000, or 31% to $89,000of $2,361,000 and $6,886,000 for the third quarter and year-to-date fiscal period ended May 31, 2022,2023, respectively, compared to $68,000 in the prior year comparable period. Interest expense increased $58,000, or 28%$89,000 and $262,000 for the first nine months of fiscal 2022, compared to $204,000 in the prior comparable period. As the Company had no outstanding balance on its revolving debt facility for both periods,third quarter and year-to-date fiscal period, respectively. The increase in interest expense has remained relatively low.relates to our outstanding long-term debt which was used to fund our NuCera business acquisition at the beginning of fiscal 2023.
Other (Expense) Income (Expense)
Other (expense) income (expense) was an expense of $166,000($308,000) in the quarter ended May 31, 2022,2023, compared to an expense of $260,000($166,000) in the same period in the prior year, a difference of $94,000.$142,000. Other (expense) income (expense) was incomean expense of $231,000($1,130,000) in the first nine months of the fiscal year compared to an expenseincome of $758,000$231,000 in the comparable period, a difference of $989,000.$1,361,000. Other (expense) income (expense) primarily includes foreign exchange gains (losses) caused by changes in exchange rates on transactions or balances denominated in currencies other than the functional currency of our subsidiaries, non-service cost components of periodic pension expense (including pension-related settlement costs due to the timing of lump-sum distributions), interest income, rental income and other non-trade/non-royalty/non-commission receipts. The change in total other (expense) income (expense) in fiscal 20222023 compared to fiscal 20212022 for both the quarter-to-datethird quarter and year-to-date periodsnine-month period was largely due to the recognition of neta foreign exchange gainsloss in fiscal 20222023 as compared to a net lossesforeign exchange gain in fiscal 2021.2022.
Income Taxes
For the three and nine months ended May 31, 2023, the Company’s recognized effective tax rate was 25.1% and 23.6%, respectively. For the three and nine months ended May 31, 2022, the Company’s recognized effective tax rate was 19.7% and 23.3%, respectively. For the three and nine months ended May 31, 2021, the Company’s recognized effective tax rate was 19.5% and 23.1%, respectively.
For fiscal 20222023 and 2021,2022, the Company is utilizing the 21% Federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Act”) passed in December 2017. Please see Note 14 — “Income Taxes” to the Condensed Consolidated Financial Statements for further discussion of the effects of the Tax Act.
Net Income
Net income increased $1,256,000,decreased $3,453,000, or 9%22.2% to $15,545,000$12,092,000 in the quarter ended May 31, 20222023 compared to $14,289,000$15,545,000 in the comparable prior year third quarter. Net income increased $101,000,decreased $7,079,000, or less than 1%21% to $27,319,000 in the nine-month period ended May 31, 2023 compared to $34,398,000 in the nine month year-to-date period ended May 31, 2022 compared to $34,297,000 in the comparable nine month year-to-date prior nine-month period. The increasedecrease in net income is predominately caused by an increase in operating expenses and interest expense in the third quarter and year-to-date period was primarily duefiscal period. This includes incremental depreciation and amortization related to sales increases in its lower margin Industrial Tapes segment outpacing revenue gains seen in its higher margin Adhesives, Sealantsour NuCera business, lease impairment/write-off of right of use asset, and Additives segment and Corrosion Protection and Waterproofing segments.first quarter purchase accounting adjustments related to the NuCera acquisition, which include backlog fully amortized during the first fiscal quarter – all of which negatively impacted net income over the comparable prior year quarter.
38
Liquidity and Sources of Capital
The Company’s overall cash and cash equivalents balance increased $5,254,000decreased by $272,424,000 to $124,683,000$43,071,000 at May 31, 2022,2023, from $119,429,000$315,495,000 at August 31, 2021.2022. The increaselower cash balance at May 31, 2023 was attributed to the $180,000,000 of cash drawn from the revolving credit facility prior to the end of fiscal 2022, the proceeds of which were used, together with $70,000,000 in cash on hand, to fund the acquisition of NuCera which closed on September 1, 2022 (the first day of fiscal 2023). The decrease in cash balance at May 31, 2023 is primarily attributable tooffset by cash provided by operations of $20,286,000 offset by the $9,460,000 annual dividend in the second quarter of fiscal 2022 and the continued strategic inventory build over the first half and third quarter of fiscal 2022. $41,815,000.
Of the above-noted amounts, $30,402,000balances, $22,714,000 and $26,309,000$28,951,000 were held outside the United States by Chase Corporation and its foreign subsidiaries as of May 31, 20222023 and August 31, 2021,2022, respectively. Given the Company’s cash position and borrowing capability in the United States and the potential for increased investment and acquisitions in foreign jurisdictions, prior to the second quarter of fiscal 2018 the Company did not have a history of repatriating a significant
40
portion of its foreign cash. With the passage of the Tax Cuts and Jobs Act (the “Tax Act”) in the second fiscal quarter of fiscal 2018, significant changes in the Internal Revenue Code were enacted, changing the U.S. taxable nature of previously unrepatriated foreign earnings. Following the passage of the Tax Act, the Company repatriated $10,499,000 in U.K. foreign earnings in fiscal 2018 and $17,230,000 in fiscal 2019. No additional amounts were repatriated in fiscal year 2020, 2021, or 2022. The Company repatriated $0 and $11,458,000 in U.K. foreign earnings in third quarter and year-to-date period of fiscal period 2022.2023. Please see Note 14 — “Income Taxes” to the Condensed Consolidated Financial Statements for further discussion of the effects of the Tax Act.
Cash flow provided by operations was $20,286,000$41,815,000 in the first nine months of fiscal year 20222023 compared to $43,000,000$20,286,000 in the same period of the comparable year. CashThe increase in cash provided by operations during the current period compared to the prior year was primarily related to operating income. Negatively impacting the cash flow from operationsincrease in the current period wasrevenue, mainly driven by our continued strategicNuCera business and reduction on inventory build, undertaken to help ensure our ability to satisfy our customers’ demands and to address our elevated backlog caused in part by macroeconomic supply chain challenges.spend.
The ratio of current assets to current liabilities was 8.05.2 as of May 31, 20222023 compared to 6.512.4 (or 7.3 excluding the $180,000,000 cash drawn from our revolving credit facility to fund the NuCera acquisition) as of August 31, 2021,2022. The decrease in the ratio of current assets to current liabilities is primarily due to the year-to-date increase in cash and inventory balance offset by decreases in accounts payable and accrued payroll and other compensation balances.outflow of $250,000,000 to fund the acquisition of NuCera mentioned above.
Cash flow used in investing activities of $3,443,000$255,523,000 was largelyprimarily due to the cash spentpurchase of NuCera, which occurred on capital purchases of machinery and equipment in the first nine monthsday of fiscal 2022.2023.
Cash flows used in financing activities of $9,460,000$59,823,000 was due to principal payments (totaling $50,000,000) on our long-term debt related to the funding of the NuCera acquisition mentioned above. Additionally, the cash flows used in financing activities was due to a cash dividend of $1.00 per share. The dividend was paid on December 9, 2021share (totaling $9,500,000) to shareholders of record on November 30, 2021.2022 and paid on December 9, 2022, the second quarter of fiscal 2023.
On July 27, 2021 (the fourth quarter of fiscal 2021), the Company entered into the Second Amended and Restated Credit Agreement (the “New Credit“Credit Agreement”) by and among the Company and NEPTCO Incorporated (“NEPTCO”), each of theas borrowers, the subsidiary guarantorsguarantor subsidiaries party thereto, the financial institutions party thereto as Lenders, and Bank of America, N.A., as administrative agent, with participation from Wells Fargo Bank, N.A., PNC Bank, N.A. and JPMorgan Chase Bank, N.A. The New Credit Agreement was entered into to amend, restate and extend the Company’s preexisting credit facility, which had a maturity date of December 15, 2021,is used to provide for additional liquidity to finance acquisitions, working capital and capital expenditures, and for other general corporate purposes. Under the NewThe Credit Agreement Chase obtained an increasedincludes a revolving credit loan (the “New Revolving“Revolving Facility”), with borrowing capabilities not to exceed $200,000,000 at any time, with the ability to request an increase in this amount by an additional $100,000,000 at the individual or collective option of any of the Lenders. Effective February 1, 2023, the Credit Agreement transitioned to a secured overnight financing rate (SOFR) in substitution for the London Interbank Offered Rate (LIBOR) and will commence at the next interest rate renewal period. The applicable interest rate for the New Revolving Facility and New Term Loan (defined below) is based on the effective London Interbank Offered Rate (LIBOR)SOFR base rate plus a rangeSOFR adjustment based on the term of the interest rate period plus a spread ranging from 1.00% to 1.75%, depending on the consolidated net leverage ratio of Chase and its subsidiaries. AtThe SOFR adjustment is based on interest rate periods of 1-month at .1%, 3-months at .15%, and 6-months at .25%. Prior to the transition to SOFR, the applicable interest rate for the Revolving Facility and Term Loan (defined below) is based on the effective LIBOR plus a spread ranging from 1.00% to 1.75%, depending on the consolidated net leverage ratio of Chase and its subsidiaries. As of May 31, 2022, there was no outstanding principal balance, and as such, no applicable2023, the Company had $130,000,000 in long-term debt attributed to the acquisition of NuCera Solutions that closed on September 1, 2022. The long-term debt has a weighted average interest rate. rate of 6.6%.
The New Credit Agreement has a five-year term with interest payments due at the end of the applicable LIBOR or SOFR period (but in no event less frequently than the three-month anniversary of the commencement of such LIBOR or SOFR period) and principal payment due at the expiration of the agreement, July 27, 2026. The New Credit Agreement contains provisions that may replace LIBOR as the benchmark index under certain circumstances. In addition, the Company may elect a base rate option for all or a portion of the New Revolving Facility, in which case interest payments shall be due with respect to such portion of the New Revolving Facility on the last business day of each quarter. Subject to certain conditions set forth in the New Credit Agreement, the Company may elect to convert all or a portion of the outstanding New Revolving Facility into a new term loan twice during the term of the New Revolving Facility (each, a “New Term“Term Loan”, and collectively with the
39
New Revolving Facility, the “New Credit“Credit Facility”), which New Term Loan shall be payable quarterly in equal installments sufficient to amortize the original principal amount of such Term Loan on a ten year amortization schedule.
41
The outstanding balance on the New Credit Facility is guaranteed by all of Chase’s direct and indirect domestic subsidiaries.subsidiaries, which collectively had a carrying value of approximately $328,788,000 at May 31, 2023. The New Credit Facility is subject to restrictive covenants under the New Credit Agreement, and financial covenants that require Chase and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a consolidated net leverage ratio of no greater than 3.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.50 to 1.00 (both defined in the New Credit Agreement). Chase Corporation was in compliance with the debt covenants as of May 31, 2022. The New Credit Agreement also placesrequires lender approval for acquisitions over a certain Lender-approval requirements as to the size of permitted acquisitions which may be entered into by the Company and its subsidiaries, and allows for a temporary step-up in the allowed consolidated leverage ratio, to 3.75 to 1.00, for the four fiscal quarters ending after certain designated acquisitions.acquisitions, including the NuCera acquisition in the first quarter of fiscal 2023. Prepayment is allowed by the New Credit Agreement at any time during the term of the agreement, subject to customary notice requirements and the payment of customary LIBOR or SOFR breakage fees. Chase Corporation was in compliance with the debt covenants as of May 31, 2023.
The Company has several ongoing capital projects, including upgrading the Company’s ERP system, as well as its facility rationalization and consolidation initiative, which are important to its long-term strategic goals. Machinery and equipment may be added as needed to increase capacity or enhance operating efficiencies in the Company’s production facilities.
We may acquire companies or other assets in future periods which are complementary to our business. The acquisition of ABchimie included a potential earnout based on performance of up to an additional €7,000,000 (approximately $8,330,000 at the time of the transaction), which the Company expects to pay with cash on hand if the applicable conditions are met. The acquisition of ETi includes a $1,000,000 withholding, which is payable by the Company within eighteen months of the acquisition. The Company believes that its existing resources, including cash on hand and the New Amended and Restated Credit Agreement, together with cash generated from operations and additional bank borrowings, will be sufficient to fund its cash flow requirements through at least the next twelve months. However, there can be no assurance that additional financing, if needed, will be available on favorable terms, if at all.
To the extent that interest rates increase in future periods, we will assess the impact of these higher interest rates on the financial and cash flow projections of our potential acquisitions.
We have no material off-balance sheet arrangements.
4042
Contractual Obligations
Please refer to Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 20212022 for a complete discussion of itsthe Company’s contractual obligations.
Recent Accounting Standards
Please see Note 2— “Recent “Recent Accounting Standards” to the Condensed Consolidated Financial Statements for a discussion of the effects of recently issued and recently adopted accounting pronouncements.
Critical Accounting Policies
Our financial statements are prepared in accordance with accounting principles generally accepted in the United States.U.S. GAAP. To apply these principles, we must make estimates and judgments that affect our reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. In many instances, we reasonably could have used different accounting estimates and, in other instances, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates and judgments on historical experience and other assumptions that we believe to be reasonable at the time and under the circumstances, and we evaluate these estimates and judgments on an ongoing basis. We refer to accounting estimates and judgments of this type as critical accounting policies, judgments, and estimates. Management believes there have been no material changes during the nine months ended May 31, 20222023 to the critical accounting policies reported in Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2021.2022.
4143
Item 3 — Quantitative and Qualitative Disclosures about Market Risk
Chase Corporation limits the amount of credit exposure to any one issuer. At May 31, 2022,2023, other than the Company’s restricted investments (which are restricted for use in non-qualified retirement savings plans for certain key employees and members of the Board of Directors), all of itsthe Company’s funds were either in demand deposit accounts or investment instruments that meet high credit quality standards, such as money market funds, government securities, or commercial paper.
Chase Corporation’sChase’s U.S. operations have limited currency exposure since substantially all transactions are denominated in U.S. dollars. However, the Company’s European and Asian operations are subject to currency exchange fluctuations. The Company continues to review its policies and procedures to control this exposure while maintaining the benefit from these operations and sales not denominated in U.S. dollars. The effect of an immediate hypothetical 10% change in the exchange rate between the British pound and the U.S. dollar and the Euro and the U.S. dollar would not have a material direct effect on the Company’s overall liquidity. As of May 31, 2022,2023, the Company had cash balances in the following foreign currencies (with USD equivalents, dollars in thousands):
| | | | | | | | | | | |
Currency Code |
| Currency Name |
| USD Equivalent at May 31, 2022 |
|
| Currency Name |
| USD Equivalent at May 31, 2023 | ||
GBP |
| British Pound | | $ | 17,383 | |
| British Pound | | $ | 9,379 |
EUR |
| Euro | | $ | 6,518 | |
| Euro | | $ | 8,881 |
INR |
| Indian Rupee | | $ | 1,260 | ||||||
CAD |
| Canadian Dollar | | $ | 2,528 | |
| Canadian Dollar | | $ | 677 |
CNY |
| Chinese Yuan | | $ | 421 | |
| Chinese Yuan | | $ | 246 |
INR |
| Indian Rupee | | $ | 223 | | |||||
| | | | | | | |||||
SGD |
| Singapore Dollar | | $ | 181 |
The Company will continue to review its current cash balances denominated in foreign currency consideringin light of current tax guidelines, including the impact of the Tax Act to the U.S. Internal Revenue Code, working capital requirements, infrastructure improvements and potential acquisitions.
The Company recognized a foreign currency translation lossgain for the nine months ended May 31, 20222023 in the amount of $5,178,000$4,064,000 related to Chase Corporation’sits European, Asian and Indian operations, which is recorded in other comprehensive income (loss) within its Statement of Equity and Statement of Comprehensive Income. The Company does not have or utilize any derivative financial instruments.
The Company pays interest on its outstanding long-term debt at interest rates that fluctuate based upon changes in various base interest rates. There was noan outstanding balance of long-term debt onof $130,000,000 at May 31, 2022.2023. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Sources of Capital,” together with Note 12 — “Fair Value Measurements” and Note 16 — “Long-Term Debt” to the Condensed Consolidated Financial Statements for additional information regarding the Company’s outstanding long-term debt. The effect of anAn immediate hypothetical 10% change in variable interest rates would not have a material effect on our Consolidated Financial Statements.
4244
Item 4 — Controls and Procedures
Evaluation of disclosure controls and procedures
The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in Chase Corporation’sits reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to its management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
The Company carries out a variety of ongoing procedures under the supervision and with the participation of its management, including its Chief Executive Officer and Chief Financial Officer, to evaluate the effectiveness of the design and operation of its disclosure controls and procedures. Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that its disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.
Changes in internal control over financial reporting
ThereThe Company initiated the process of reviewing and implementing financial internal controls in the first quarter of the fiscal year on the operations associated with NuCera, acquired in September 2022. The Company continues to review and implement financial internal controls on the operations associated with NuCera during the third quarter and year-to-date period of the fiscal year.
Other than the foregoing, there have not been any changes in the Company’s internal control over financial reporting during the quarter ended May 31, 20222023 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.
4345
Part II — OTHER INFORMATION
Item 1 — Legal Proceedings
The Company is involved from time to time in litigation incidental to the conduct of its business. Although the Company does not expect that the outcome in any of these matters, individually or collectively, will have a material adverse effect on its financial condition, results of operations or cash flows, litigation is inherently unpredictable. Therefore, judgments could be rendered, or settlements agreed to, that could adversely affect the Company’s operating results or cash flows in a particular period. The Company routinely assesses all of its litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.
Item 1A — Risk Factors
Please refer to Item 1A in our Annual Report on Form 10-K for the fiscal year ended August 31, 20212022 for a complete discussion of the risk factors which could materially affect our business, financial condition or future results.
Item 6 — Exhibits
| ||
Exhibit | | Description |
| | |
31.1 | | |
31.2 | | |
32.1 | | |
32.2 | | |
101 | | The following materials from this Quarterly Report on Form 10-Q, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statement of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Unaudited Condensed Consolidated Financial Statements. |
104 | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
*Furnished, not filed
**Identifies management plan or compensatory plan or arrangement.
4446
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | |
| Chase Corporation | |
| | |
| | |
Dated: July | By: | /s/ Adam P. Chase |
| | Adam P. Chase |
| | President and Chief Executive Officer |
| | |
| | |
Dated: July | By: | /s/ Michael J. Bourque |
| | Michael J. Bourque |
| | Treasurer and Chief Financial Officer |
4547